 Connection
Barry Uretsky to Humans
This is a "connection" page, showing publications Barry Uretsky has written about Humans.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
3.086 |
|
|
|
-
Chaus A, Uretsky BF. Flow Matters: Optimizing Invasive Coronary Physiology to Improve Long-Term Outcomes. Cardiovasc Drugs Ther. 2024 Oct; 38(5):971-972.
Score: 0.037
-
Chaus A, Uretsky BF. Treating cardiac tamponade due to malignant effusion with percutaneous balloon pericardiotomy: Back to the future. Catheter Cardiovasc Interv. 2024 03; 103(4):682-683.
Score: 0.036
-
Hassanin A, Al-Azizi K, Uretsky BF. Occupational Safety in the Cardiac Catheterization Laboratory: Time for Better Ergonomics. JACC Cardiovasc Interv. 2023 05 22; 16(10):1236-1238.
Score: 0.034
-
Chaus A, Uretsky BF. Bifurcation stenting: If the shoe doesn't fit. Catheter Cardiovasc Interv. 2023 01; 101(1):58-59.
Score: 0.033
-
Uretsky BF, Agarwal SK, Vallurupalli S, Al-Hawwas M, Miller K, Biscaglia S, Hakeem A. Trans-Stent FFR Gradient as a Modifiable Integrant in Predicting Long-Term Target Vessel Failure. JACC Cardiovasc Interv. 2022 11 14; 15(21):2192-2202.
Score: 0.033
-
Chaus A, Uretsky BF. Bioresorbable Vascular Scaffolds: a Dissolving Dream? Cardiovasc Drugs Ther. 2023 02; 37(1):1-3.
Score: 0.033
-
Birnbaum Y, Uretsky BF. How electrically silent is the pericardium? Heart. 2022 08 25; 108(18):1428-1429.
Score: 0.032
-
Vallurupalli S, Hess E, Plomondon ME, Park K, Waldo SW, Agarwal S, Uretsky BF. Impact of severity of baseline thrombocytopenia on outcomes after percutaneous coronary interventions: Analysis from the Veterans Affairs Clinical Assessment, Reporting, and Tracking (VA CART) Program. Catheter Cardiovasc Interv. 2022 04; 99(5):1491-1497.
Score: 0.031
-
Chaus A, Uretsky BF. SYNTAX Score for Clinical Decision-Making: Necessity, Nicety, or Neither? Cardiovasc Revasc Med. 2022 04; 37:90-91.
Score: 0.031
-
Soomro AY, Almaddah N, Lendel V, Agarwal SK, Uretsky BF. Elective percutaneous coronary intervention performed during contrast-induced hypotension. Catheter Cardiovasc Interv. 2022 02; 99(3):772-776.
Score: 0.030
-
Hakeem A, Hou L, Shah K, Agarwal SK, Almomani A, Edupuganti M, Kasula S, Pothineni NV, Al-Hawwas M, Miller K, Zakir R, Ghosh B, Uretsky BF. Derivation and validation of Pd/Pa in the assessment of residual ischemia post-intervention: A prospective all-comer registry. Catheter Cardiovasc Interv. 2022 02; 99(3):714-722.
Score: 0.030
-
Agarwal SK, Uretsky BF. Is it time for a "functional" hybrid algorithm to optimize interventional results in chronic total occlusion? Catheter Cardiovasc Interv. 2021 03; 97(4):656-657.
Score: 0.029
-
Agarwal SK, Hakeem A, Hasan R, Ayan M, Siraj A, Madmani ME, Rafeedheen R, Salehi N, Kasula S, Hacioglu Y, Miller K, Vallurupalli S, Al-Hawwas M, Uretsky BF. Fractional Flow Reserve After Functionally Optimized Coronary Intervention Predicts Very Long-Term Outcomes. JACC Cardiovasc Interv. 2021 02 08; 14(3):355-356.
Score: 0.029
-
Uretsky BF, Agarwal SK, Vallurupalli S, Al-Hawwas M, Hasan R, Miller K, Hakeem A. Prospective Evaluation of the Strategy of Functionally Optimized Coronary Intervention. J Am Heart Assoc. 2020 02 04; 9(3):e015073.
Score: 0.027
-
Hakeem A, Ghosh B, Shah K, Agarwal S, Kasula S, Hacioglu Y, Bhatti S, Ahmed Z, Uretsky B. Incremental Prognostic Value of Post-Intervention Pd/Pa in Patients Undergoing Ischemia-Driven Percutaneous Coronary Intervention. JACC Cardiovasc Interv. 2019 10 28; 12(20):2002-2014.
Score: 0.027
-
Uretsky BF, Vallurupalli S. Is the Digitalis Leaf Still Withering? J Am Coll Cardiol. 2019 08 06; 74(5):628-630.
Score: 0.026
-
Rafeedheen R, Agarwal SK, Meek JC, Uretsky BF. Use of "super-glue" to seal a perforation during chronic total occlusion coronary intervention and the potential to "unglue" it. Catheter Cardiovasc Interv. 2020 05 01; 95(6):1136-1140.
Score: 0.026
-
Uretsky BF, Linsky N, Turi ZG. A man of service. Catheter Cardiovasc Interv. 2019 Jul 01; 94(1):27-28.
Score: 0.026
-
Hakeem A, Uretsky BF. Role of Postintervention Fractional Flow Reserve to Improve Procedural and Clinical Outcomes. Circulation. 2019 01 29; 139(5):694-706.
Score: 0.025
-
Siraj A, Pattanshetty DJ, Agarwal SK, Uretsky BF. Retrograde recanalization of a nonchronic total occlusion lesion. Catheter Cardiovasc Interv. 2018 12 01; 92(7):1293-1296.
Score: 0.025
-
Abdel-Karim AR, Uretsky BF. The importance of malapposition in angiographically optimized stenting in contemporaneous interventions. Expert Rev Cardiovasc Ther. 2018 Aug; 16(8):599-605.
Score: 0.024
-
Uretsky BF. All stent strut malappositions are not created equal. Catheter Cardiovasc Interv. 2018 02 15; 91(3):376-377.
Score: 0.024
-
Hakeem A, Almomani A, Uretsky BF. Role of fractional flow reserve in the evaluation and management of patients with acute coronary syndrome. Curr Opin Cardiol. 2017 11; 32(6):767-775.
Score: 0.023
-
Vallurupalli S, Garg A, Carlino M, Hakeem A, Uretsky BF. Full stent expansion of chronic total occlusion lesions requires prolonged inflation. Cardiovasc Revasc Med. 2018 06; 19(4):403-406.
Score: 0.023
-
Hakeem A, Uretsky BF. Clinical and Prognostic Value of Post-Stenting FFR. JACC Cardiovasc Interv. 2017 08 14; 10(15):1596.
Score: 0.023
-
Vallurupalli S, Uretsky BF. Letter by Vallurupalli and Uretsky Regarding Article, "Optical Coherence Tomography to Optimize Results of Percutaneous Coronary Intervention in Patients With Non-ST-Elevation Acute Coronary Syndrome: Results of the Multicenter, Randomized DOCTORS Study (Does Optical Coherence Tomography Optimize Results of Stenting)". Circulation. 2017 02 28; 135(9):e140-e141.
Score: 0.022
-
Agrawal M, Hakeem A, Ahmed Z, Uretsky BF. Classification of mechanisms of strut malapposition after angiographically optimized stent implantation: An optical coherence tomography study. Catheter Cardiovasc Interv. 2017 Aug 01; 90(2):225-232.
Score: 0.022
-
Vallurupalli S, Kasula S, Kumar Agarwal S, Pothineni NVK, Abualsuod A, Hakeem A, Ahmed Z, Uretsky BF. A novel stent inflation protocol improves long-term outcomes compared with rapid inflation/deflation deployment method. Catheter Cardiovasc Interv. 2017 Aug 01; 90(2):233-240.
Score: 0.022
-
Vallurupalli S, Uretsky BF. Deploying bioresorbable vascular scaffolds--tardus, altius, amplius!! Catheter Cardiovasc Interv. 2016 Apr; 87(5):847-8.
Score: 0.021
-
Hakeem A, Garg A, Bhatti S, Ahmed Z, Uretsky BF. Fractional flow reserve in acute coronary syndrome: a word of caution. EuroIntervention. 2015 Dec; 11(8):e1-2.
Score: 0.020
-
Vallurupalli S, Bahia A, Ruiz-Rodriguez E, Ahmed Z, Hakeem A, Uretsky BF. Optimization of stent implantation using a high pressure inflation protocol. Catheter Cardiovasc Interv. 2016 Jan 01; 87(1):65-72.
Score: 0.020
-
Uretsky BF, Mathew J, Ahmed Z, Hakeem A. Percutaneous management of patients with acute coronary syndromes from unprotected left main disease: A comprehensive review and presentation of a treatment algorithm. Catheter Cardiovasc Interv. 2016 Jan 01; 87(1):90-100.
Score: 0.020
-
Hakeem A, Uretsky BF. "Just do it!" redux. Catheter Cardiovasc Interv. 2015 May; 85(6):977-8.
Score: 0.020
-
Assad-Kottner C, Hakeem A, Uretsky BF. Modified dual guide catheter ("ping-pong") technique to treat left internal mammary artery graft perforation. Catheter Cardiovasc Interv. 2015 Jul; 86(1):E28-31.
Score: 0.019
-
Uretsky BF, Carlino M. How to improve your "STAR quality". Catheter Cardiovasc Interv. 2015 Feb 15; 85(3):391-2.
Score: 0.019
-
Hakeem A, Uretsky B. Regadenoson for FFR: time to say good-bye to adenosine? Catheter Cardiovasc Interv. 2014 Feb 15; 83(3):375-6.
Score: 0.018
-
Assad-Kottner C, Hakeem A, Fontenot E, Uretsky BF. "Tele-mentoring": an interventional procedure using a wearable computer: first-in-man. J Am Coll Cardiol. 2014 Mar 18; 63(10):1022.
Score: 0.018
-
Garg N, Hakeem A, Gobal F, Uretsky BF. Outcomes of percutaneous coronary intervention of chronic total saphenous vein graft occlusions in the contemporary era. Catheter Cardiovasc Interv. 2014 Jun 01; 83(7):1025-32.
Score: 0.018
-
Sachdeva R, Agrawal M, Flynn SE, Werner GS, Uretsky BF. Rebuttal: response to letter by Fan and colleagues regarding "impact on fractional flow reserve of donor artery by chronic total obstruction revascularization". Catheter Cardiovasc Interv. 2013 Dec 01; 82(7):1197.
Score: 0.017
-
Sachdeva R, Agrawal M, Flynn SE, Werner GS, Uretsky BF. Reversal of ischemia of donor artery myocardium after recanalization of a chronic total occlusion. Catheter Cardiovasc Interv. 2013 Oct 01; 82(4):E453-8.
Score: 0.017
-
Uretsky BF. Pathophysiology and prognosis: the curious case of the periprocedural myocardial infarction. Catheter Cardiovasc Interv. 2013 May; 81(6):968-9.
Score: 0.017
-
Singla S, Sachdeva R, Uretsky BF. The risk of adverse cardiac and bleeding events following noncardiac surgery relative to antiplatelet therapy in patients with prior percutaneous coronary intervention. J Am Coll Cardiol. 2012 Nov 13; 60(20):2005-16.
Score: 0.016
-
Deshmukh AJ, Pant S, Cook J, Sachdeva R, Rutlen D, Uretsky BF. Prasugrel-induced rash. Ann Pharmacother. 2012 Jul-Aug; 46(7-8):1123-5.
Score: 0.016
-
Uretsky BF. Does mini-STAR equal mega-success? Catheter Cardiovasc Interv. 2012 Jan 01; 79(1):41-2.
Score: 0.016
-
Uretsky BF. The value of recanalizing a chronic total occlusion. Catheter Cardiovasc Interv. 2011 Sep 01; 78(3):354-5.
Score: 0.015
-
Uretsky BF. Should serum troponin after PCI be used to predict long-term outcomes?.......Not quite yet! Catheter Cardiovasc Interv. 2011 Jun 01; 77(7):1031-2.
Score: 0.015
-
Uretsky BF. Letter by Uretsky regarding article, "Outcomes in patients with de novo left main disease treated with either percutaneous coronary intervention using paclitaxel-eluting stents or coronary artery bypass graft treatment in the synergy between percutaneous coronary intervention with TAXUS and cardiac surgery (SYNTAX) trial". Circulation. 2011 Apr 05; 123(13):e398; author reply e399.
Score: 0.015
-
Sachdeva R, Uretsky BF. The effect of CTO recanalization on FFR of the donor artery. Catheter Cardiovasc Interv. 2011 Feb 15; 77(3):367-9.
Score: 0.015
-
Sudhakar S, Sewani A, Agrawal M, Uretsky BF. Pseudoaneurysm of the mitral-aortic intervalvular fibrosa (MAIVF): A comprehensive review. J Am Soc Echocardiogr. 2010 Oct; 23(10):1009-18; quiz 1112.
Score: 0.014
-
Uretsky BF. Primary PCI for the "late presenter" with STEMI: how late is too late? Catheter Cardiovasc Interv. 2010 Oct 01; 76(4):471-2.
Score: 0.014
-
Uretsky BF. IIb or not IIb? Toward a rational application of left main stenting. J Am Coll Cardiol. 2010 Jun 08; 55(23):2553-5.
Score: 0.014
-
Sachdeva R, Hughes B, Uretsky BF. Retrograde approach to a totally occluded right coronary artery via a septal perforator artery: the tale of a long and winding wire. J Invasive Cardiol. 2010 Apr; 22(4):E65-6.
Score: 0.014
-
Sachdeva R, Uretsky BF. Retrograde recanalization of a chronic total occlusion of a saphenous vein graft. Catheter Cardiovasc Interv. 2009 Oct 01; 74(4):575-8.
Score: 0.013
-
Uretsky BF. "Drip-and-ship," "Stay-and-pray," "Freight-and-wait (and possibly inflate)" or simply opening the window wider?: Decision-making regarding time delays in the treatment of ST elevation MI. Catheter Cardiovasc Interv. 2009 Sep 01; 74(3):406-7.
Score: 0.013
-
Uretsky BF. Optimizing bifurcation stenting: the SPRINT technique. Catheter Cardiovasc Interv. 2009 Feb 15; 73(3):344-5.
Score: 0.013
-
Uretsky BF. Treating the left main bifurcation lesion: the "three stent solution". Catheter Cardiovasc Interv. 2009 Jan 01; 73(1):42-3.
Score: 0.013
-
Uretsky BF. Can I be a star (or at least perform one)? Catheter Cardiovasc Interv. 2008 Nov 15; 72(6):797-8.
Score: 0.012
-
Uretsky BF. Advancing backward: a word of caution. Catheter Cardiovasc Interv. 2008 Sep 01; 72(3):379-380.
Score: 0.012
-
Uretsky B. A new tool to treat the chronically occluded coronary artery? Catheter Cardiovasc Interv. 2008 Aug 01; 72(2):164-5.
Score: 0.012
-
Uretsky BF. Thrombus aspiration during primary percutaneous coronary intervention. N Engl J Med. 2008 Jun 12; 358(24):2639; author reply 2640-1.
Score: 0.012
-
Sonderman KA, Wolf LL, Armstrong LB, Taylor K, Jiang W, Weil BR, Koehlmoos TP, Ricca RL, Weldon CB, Haider AH, Rice-Townsend SE. Testicular atrophy following inguinal hernia repair in children. Pediatr Surg Int. 2018 May; 34(5):553-560.
Score: 0.012
-
Sonderman KA, Wolf LL, Armstrong LB, Taylor K, Jiang W, Weil BR, Koehlmoos TP, Ricca RL, Weldon CB, Haider AH, Rice-Townsend SE. Testicular atrophy following inguinal hernia repair in children. Pediatr Surg Int. 2018 May; 34(5):553-560.
Score: 0.012
-
Sonderman KA, Wolf LL, Armstrong LB, Taylor K, Jiang W, Weil BR, Koehlmoos TP, Ricca RL, Weldon CB, Haider AH, Rice-Townsend SE. Testicular atrophy following inguinal hernia repair in children. Pediatr Surg Int. 2018 May; 34(5):553-560.
Score: 0.012
-
Sonderman KA, Wolf LL, Armstrong LB, Taylor K, Jiang W, Weil BR, Koehlmoos TP, Ricca RL, Weldon CB, Haider AH, Rice-Townsend SE. Testicular atrophy following inguinal hernia repair in children. Pediatr Surg Int. 2018 May; 34(5):553-560.
Score: 0.012
-
Sonderman KA, Wolf LL, Armstrong LB, Taylor K, Jiang W, Weil BR, Koehlmoos TP, Ricca RL, Weldon CB, Haider AH, Rice-Townsend SE. Testicular atrophy following inguinal hernia repair in children. Pediatr Surg Int. 2018 May; 34(5):553-560.
Score: 0.012
-
Sonderman KA, Wolf LL, Armstrong LB, Taylor K, Jiang W, Weil BR, Koehlmoos TP, Ricca RL, Weldon CB, Haider AH, Rice-Townsend SE. Testicular atrophy following inguinal hernia repair in children. Pediatr Surg Int. 2018 May; 34(5):553-560.
Score: 0.012
-
Sonderman KA, Wolf LL, Armstrong LB, Taylor K, Jiang W, Weil BR, Koehlmoos TP, Ricca RL, Weldon CB, Haider AH, Rice-Townsend SE. Testicular atrophy following inguinal hernia repair in children. Pediatr Surg Int. 2018 May; 34(5):553-560.
Score: 0.012
-
Sonderman KA, Wolf LL, Armstrong LB, Taylor K, Jiang W, Weil BR, Koehlmoos TP, Ricca RL, Weldon CB, Haider AH, Rice-Townsend SE. Testicular atrophy following inguinal hernia repair in children. Pediatr Surg Int. 2018 May; 34(5):553-560.
Score: 0.012
-
Sonderman KA, Wolf LL, Armstrong LB, Taylor K, Jiang W, Weil BR, Koehlmoos TP, Ricca RL, Weldon CB, Haider AH, Rice-Townsend SE. Testicular atrophy following inguinal hernia repair in children. Pediatr Surg Int. 2018 May; 34(5):553-560.
Score: 0.012
-
Sonderman KA, Wolf LL, Armstrong LB, Taylor K, Jiang W, Weil BR, Koehlmoos TP, Ricca RL, Weldon CB, Haider AH, Rice-Townsend SE. Testicular atrophy following inguinal hernia repair in children. Pediatr Surg Int. 2018 May; 34(5):553-560.
Score: 0.012
-
Sonderman KA, Wolf LL, Armstrong LB, Taylor K, Jiang W, Weil BR, Koehlmoos TP, Ricca RL, Weldon CB, Haider AH, Rice-Townsend SE. Testicular atrophy following inguinal hernia repair in children. Pediatr Surg Int. 2018 May; 34(5):553-560.
Score: 0.012
-
Sonderman KA, Wolf LL, Armstrong LB, Taylor K, Jiang W, Weil BR, Koehlmoos TP, Ricca RL, Weldon CB, Haider AH, Rice-Townsend SE. Testicular atrophy following inguinal hernia repair in children. Pediatr Surg Int. 2018 May; 34(5):553-560.
Score: 0.012
-
Sonderman KA, Wolf LL, Armstrong LB, Taylor K, Jiang W, Weil BR, Koehlmoos TP, Ricca RL, Weldon CB, Haider AH, Rice-Townsend SE. Testicular atrophy following inguinal hernia repair in children. Pediatr Surg Int. 2018 May; 34(5):553-560.
Score: 0.012
-
Sonderman KA, Wolf LL, Armstrong LB, Taylor K, Jiang W, Weil BR, Koehlmoos TP, Ricca RL, Weldon CB, Haider AH, Rice-Townsend SE. Testicular atrophy following inguinal hernia repair in children. Pediatr Surg Int. 2018 May; 34(5):553-560.
Score: 0.012
-
Sonderman KA, Wolf LL, Armstrong LB, Taylor K, Jiang W, Weil BR, Koehlmoos TP, Ricca RL, Weldon CB, Haider AH, Rice-Townsend SE. Testicular atrophy following inguinal hernia repair in children. Pediatr Surg Int. 2018 May; 34(5):553-560.
Score: 0.012
-
Sonderman KA, Wolf LL, Armstrong LB, Taylor K, Jiang W, Weil BR, Koehlmoos TP, Ricca RL, Weldon CB, Haider AH, Rice-Townsend SE. Testicular atrophy following inguinal hernia repair in children. Pediatr Surg Int. 2018 May; 34(5):553-560.
Score: 0.012
-
Sonderman KA, Wolf LL, Armstrong LB, Taylor K, Jiang W, Weil BR, Koehlmoos TP, Ricca RL, Weldon CB, Haider AH, Rice-Townsend SE. Testicular atrophy following inguinal hernia repair in children. Pediatr Surg Int. 2018 May; 34(5):553-560.
Score: 0.012
-
Sonderman KA, Wolf LL, Armstrong LB, Taylor K, Jiang W, Weil BR, Koehlmoos TP, Ricca RL, Weldon CB, Haider AH, Rice-Townsend SE. Testicular atrophy following inguinal hernia repair in children. Pediatr Surg Int. 2018 May; 34(5):553-560.
Score: 0.012
-
Sonderman KA, Wolf LL, Armstrong LB, Taylor K, Jiang W, Weil BR, Koehlmoos TP, Ricca RL, Weldon CB, Haider AH, Rice-Townsend SE. Testicular atrophy following inguinal hernia repair in children. Pediatr Surg Int. 2018 May; 34(5):553-560.
Score: 0.012
-
Sonderman KA, Wolf LL, Armstrong LB, Taylor K, Jiang W, Weil BR, Koehlmoos TP, Ricca RL, Weldon CB, Haider AH, Rice-Townsend SE. Testicular atrophy following inguinal hernia repair in children. Pediatr Surg Int. 2018 May; 34(5):553-560.
Score: 0.012
-
Sonderman KA, Wolf LL, Armstrong LB, Taylor K, Jiang W, Weil BR, Koehlmoos TP, Ricca RL, Weldon CB, Haider AH, Rice-Townsend SE. Testicular atrophy following inguinal hernia repair in children. Pediatr Surg Int. 2018 May; 34(5):553-560.
Score: 0.012
-
Sonderman KA, Wolf LL, Armstrong LB, Taylor K, Jiang W, Weil BR, Koehlmoos TP, Ricca RL, Weldon CB, Haider AH, Rice-Townsend SE. Testicular atrophy following inguinal hernia repair in children. Pediatr Surg Int. 2018 May; 34(5):553-560.
Score: 0.012
-
Sonderman KA, Wolf LL, Armstrong LB, Taylor K, Jiang W, Weil BR, Koehlmoos TP, Ricca RL, Weldon CB, Haider AH, Rice-Townsend SE. Testicular atrophy following inguinal hernia repair in children. Pediatr Surg Int. 2018 May; 34(5):553-560.
Score: 0.012
-
Sonderman KA, Wolf LL, Armstrong LB, Taylor K, Jiang W, Weil BR, Koehlmoos TP, Ricca RL, Weldon CB, Haider AH, Rice-Townsend SE. Testicular atrophy following inguinal hernia repair in children. Pediatr Surg Int. 2018 May; 34(5):553-560.
Score: 0.012
-
Sonderman KA, Wolf LL, Armstrong LB, Taylor K, Jiang W, Weil BR, Koehlmoos TP, Ricca RL, Weldon CB, Haider AH, Rice-Townsend SE. Testicular atrophy following inguinal hernia repair in children. Pediatr Surg Int. 2018 May; 34(5):553-560.
Score: 0.012
-
Sonderman KA, Wolf LL, Armstrong LB, Taylor K, Jiang W, Weil BR, Koehlmoos TP, Ricca RL, Weldon CB, Haider AH, Rice-Townsend SE. Testicular atrophy following inguinal hernia repair in children. Pediatr Surg Int. 2018 May; 34(5):553-560.
Score: 0.012
-
Sonderman KA, Wolf LL, Armstrong LB, Taylor K, Jiang W, Weil BR, Koehlmoos TP, Ricca RL, Weldon CB, Haider AH, Rice-Townsend SE. Testicular atrophy following inguinal hernia repair in children. Pediatr Surg Int. 2018 May; 34(5):553-560.
Score: 0.012
-
Sonderman KA, Wolf LL, Armstrong LB, Taylor K, Jiang W, Weil BR, Koehlmoos TP, Ricca RL, Weldon CB, Haider AH, Rice-Townsend SE. Testicular atrophy following inguinal hernia repair in children. Pediatr Surg Int. 2018 May; 34(5):553-560.
Score: 0.012
-
Sonderman KA, Wolf LL, Armstrong LB, Taylor K, Jiang W, Weil BR, Koehlmoos TP, Ricca RL, Weldon CB, Haider AH, Rice-Townsend SE. Testicular atrophy following inguinal hernia repair in children. Pediatr Surg Int. 2018 May; 34(5):553-560.
Score: 0.012
-
Sonderman KA, Wolf LL, Armstrong LB, Taylor K, Jiang W, Weil BR, Koehlmoos TP, Ricca RL, Weldon CB, Haider AH, Rice-Townsend SE. Testicular atrophy following inguinal hernia repair in children. Pediatr Surg Int. 2018 May; 34(5):553-560.
Score: 0.012
-
Sonderman KA, Wolf LL, Armstrong LB, Taylor K, Jiang W, Weil BR, Koehlmoos TP, Ricca RL, Weldon CB, Haider AH, Rice-Townsend SE. Testicular atrophy following inguinal hernia repair in children. Pediatr Surg Int. 2018 May; 34(5):553-560.
Score: 0.012
-
Sonderman KA, Wolf LL, Armstrong LB, Taylor K, Jiang W, Weil BR, Koehlmoos TP, Ricca RL, Weldon CB, Haider AH, Rice-Townsend SE. Testicular atrophy following inguinal hernia repair in children. Pediatr Surg Int. 2018 May; 34(5):553-560.
Score: 0.012
-
Sonderman KA, Wolf LL, Armstrong LB, Taylor K, Jiang W, Weil BR, Koehlmoos TP, Ricca RL, Weldon CB, Haider AH, Rice-Townsend SE. Testicular atrophy following inguinal hernia repair in children. Pediatr Surg Int. 2018 May; 34(5):553-560.
Score: 0.012
-
Sonderman KA, Wolf LL, Armstrong LB, Taylor K, Jiang W, Weil BR, Koehlmoos TP, Ricca RL, Weldon CB, Haider AH, Rice-Townsend SE. Testicular atrophy following inguinal hernia repair in children. Pediatr Surg Int. 2018 May; 34(5):553-560.
Score: 0.012
-
Sonderman KA, Wolf LL, Armstrong LB, Taylor K, Jiang W, Weil BR, Koehlmoos TP, Ricca RL, Weldon CB, Haider AH, Rice-Townsend SE. Testicular atrophy following inguinal hernia repair in children. Pediatr Surg Int. 2018 May; 34(5):553-560.
Score: 0.012
-
Sonderman KA, Wolf LL, Armstrong LB, Taylor K, Jiang W, Weil BR, Koehlmoos TP, Ricca RL, Weldon CB, Haider AH, Rice-Townsend SE. Testicular atrophy following inguinal hernia repair in children. Pediatr Surg Int. 2018 May; 34(5):553-560.
Score: 0.012
-
Sonderman KA, Wolf LL, Armstrong LB, Taylor K, Jiang W, Weil BR, Koehlmoos TP, Ricca RL, Weldon CB, Haider AH, Rice-Townsend SE. Testicular atrophy following inguinal hernia repair in children. Pediatr Surg Int. 2018 May; 34(5):553-560.
Score: 0.012
-
Sonderman KA, Wolf LL, Armstrong LB, Taylor K, Jiang W, Weil BR, Koehlmoos TP, Ricca RL, Weldon CB, Haider AH, Rice-Townsend SE. Testicular atrophy following inguinal hernia repair in children. Pediatr Surg Int. 2018 May; 34(5):553-560.
Score: 0.012
-
Sonderman KA, Wolf LL, Armstrong LB, Taylor K, Jiang W, Weil BR, Koehlmoos TP, Ricca RL, Weldon CB, Haider AH, Rice-Townsend SE. Testicular atrophy following inguinal hernia repair in children. Pediatr Surg Int. 2018 May; 34(5):553-560.
Score: 0.012
-
Sonderman KA, Wolf LL, Armstrong LB, Taylor K, Jiang W, Weil BR, Koehlmoos TP, Ricca RL, Weldon CB, Haider AH, Rice-Townsend SE. Testicular atrophy following inguinal hernia repair in children. Pediatr Surg Int. 2018 May; 34(5):553-560.
Score: 0.012
-
Sonderman KA, Wolf LL, Armstrong LB, Taylor K, Jiang W, Weil BR, Koehlmoos TP, Ricca RL, Weldon CB, Haider AH, Rice-Townsend SE. Testicular atrophy following inguinal hernia repair in children. Pediatr Surg Int. 2018 May; 34(5):553-560.
Score: 0.012
-
Sonderman KA, Wolf LL, Armstrong LB, Taylor K, Jiang W, Weil BR, Koehlmoos TP, Ricca RL, Weldon CB, Haider AH, Rice-Townsend SE. Testicular atrophy following inguinal hernia repair in children. Pediatr Surg Int. 2018 May; 34(5):553-560.
Score: 0.012
-
Sonderman KA, Wolf LL, Armstrong LB, Taylor K, Jiang W, Weil BR, Koehlmoos TP, Ricca RL, Weldon CB, Haider AH, Rice-Townsend SE. Testicular atrophy following inguinal hernia repair in children. Pediatr Surg Int. 2018 May; 34(5):553-560.
Score: 0.012
-
Sonderman KA, Wolf LL, Armstrong LB, Taylor K, Jiang W, Weil BR, Koehlmoos TP, Ricca RL, Weldon CB, Haider AH, Rice-Townsend SE. Testicular atrophy following inguinal hernia repair in children. Pediatr Surg Int. 2018 May; 34(5):553-560.
Score: 0.012
-
Sonderman KA, Wolf LL, Armstrong LB, Taylor K, Jiang W, Weil BR, Koehlmoos TP, Ricca RL, Weldon CB, Haider AH, Rice-Townsend SE. Testicular atrophy following inguinal hernia repair in children. Pediatr Surg Int. 2018 May; 34(5):553-560.
Score: 0.012
-
Sonderman KA, Wolf LL, Armstrong LB, Taylor K, Jiang W, Weil BR, Koehlmoos TP, Ricca RL, Weldon CB, Haider AH, Rice-Townsend SE. Testicular atrophy following inguinal hernia repair in children. Pediatr Surg Int. 2018 May; 34(5):553-560.
Score: 0.012
-
Sonderman KA, Wolf LL, Armstrong LB, Taylor K, Jiang W, Weil BR, Koehlmoos TP, Ricca RL, Weldon CB, Haider AH, Rice-Townsend SE. Testicular atrophy following inguinal hernia repair in children. Pediatr Surg Int. 2018 May; 34(5):553-560.
Score: 0.012
-
Sonderman KA, Wolf LL, Armstrong LB, Taylor K, Jiang W, Weil BR, Koehlmoos TP, Ricca RL, Weldon CB, Haider AH, Rice-Townsend SE. Testicular atrophy following inguinal hernia repair in children. Pediatr Surg Int. 2018 May; 34(5):553-560.
Score: 0.012
-
Sonderman KA, Wolf LL, Armstrong LB, Taylor K, Jiang W, Weil BR, Koehlmoos TP, Ricca RL, Weldon CB, Haider AH, Rice-Townsend SE. Testicular atrophy following inguinal hernia repair in children. Pediatr Surg Int. 2018 May; 34(5):553-560.
Score: 0.012
-
Holmes DR, Uretsky BF. Interventional cardiology: the past, present, and the future. Indian Heart J. 2007 Mar-Apr; 59(2 Suppl B):B4-8.
Score: 0.011
-
Rosanio S, Schwarz ER, Vitarelli A, Zarraga IG, Kunapuli S, Ware DL, Birnbaum Y, Tuero E, Uretsky BF. Sudden death prophylaxis in heart failure. Int J Cardiol. 2007 Jul 31; 119(3):291-6.
Score: 0.011
-
Uretsky BF, Wang FW. Implementation and application of a continuous quality improvement (CQI) program for the cardiac catheterization laboratory: one institution's 10-year experience. Catheter Cardiovasc Interv. 2006 Oct; 68(4):586-95.
Score: 0.011
-
Ahmad M, Jin Z, Xie T, Agoston I, Tiller F, Uretsky B. Live 3-d echocardiography in monitoring transcatheter closure of patent foramen ovale. Echocardiography. 2006 Jul; 23(6):525-7.
Score: 0.011
-
Gupta R, Uretsky BF. Gadodiamide-based coronary angiography in a patient with severe renal insufficiency. J Interv Cardiol. 2005 Oct; 18(5):379-83.
Score: 0.010
-
Uretsky BF. "The year of the Carotid": what I've learned (so far...). Catheter Cardiovasc Interv. 2005 Aug; 65(4):600-2.
Score: 0.010
-
Jammula P, Gupta R, Uretsky BF. Images in cardiology: Anomalous origin of the right coronary artery from the left anterior descending artery. Heart. 2005 Apr; 91(4):e30.
Score: 0.010
-
Helmy TA, Nicholson WJ, Lick S, Uretsky BF. Contained myocardial rupture: a variant linking complete and incomplete rupture. Heart. 2005 Feb; 91(2):e13.
Score: 0.010
-
Gupta R, Birnbaum Y, Uretsky BF. The renal patient with coronary artery disease: current concepts and dilemmas. J Am Coll Cardiol. 2004 Oct 06; 44(7):1343-53.
Score: 0.009
-
Gupta R, Birnbaum Y, Uretsky BF. Calculation of creatinine clearance based on unadjusted body weight leads to errors in renal and heart failure patients. Circulation. 2004 Aug 17; 110(7):e70.
Score: 0.009
-
Alturkmani H, Uretsky B, Patel S, Albadaineh M, Alqaisi O, Alaiwah M, Cross M, Abbasi D, Rollefson W. Safety and Efficacy of Enoxaparin During Low-Risk Elective Percutaneous Coronary Intervention. Am J Cardiol. 2024 05 01; 218:63-67.
Score: 0.009
-
Anzuini A, Uretsky BF. Covered stent septal ablation for hypertrophic obstruction cardiomyopathy. Circulation. 2004 Jan 20; 109(2):e6.
Score: 0.009
-
Collet C, Johnson NP, Mizukami T, Fearon WF, Berry C, Sonck J, Collison D, Koo BK, Meneveau N, Agarwal SK, Uretsky B, Hakeem A, Doh JH, Da Costa BR, Oldroyd KG, Leipsic JA, Morbiducci U, Taylor C, Ko B, Tonino PAL, Perera D, Shinke T, Chiastra C, Sposito AC, Leone AM, Muller O, Fournier S, Matsuo H, Adjedj J, Amabile N, Pir?th Z, Alfonso F, Rivero F, Ahn JM, Toth GG, Ihdayhid A, West NEJ, Amano T, Wyffels E, Munhoz D, Belmonte M, Ohashi H, Sakai K, Gallinoro E, Barbato E, Engstr?m T, Escaned J, Ali ZA, Kern MJ, Pijls NHJ, J?ni P, De Bruyne B. Impact of Post-PCI FFR Stratified by Coronary Artery. JACC Cardiovasc Interv. 2023 10 09; 16(19):2396-2408.
Score: 0.009
-
Hamaya R, Goto S, Hwang D, Zhang J, Yang S, Lee JM, Hoshino M, Nam CW, Shin ES, Doh JH, Chen SL, Toth GG, Piroth Z, Hakeem A, Uretsky BF, Hokama Y, Tanaka N, Lim HS, Ito T, Matsuo A, Azzalini L, Leesar MA, Collet C, Koo BK, De Bruyne B, Kakuta T. Machine-learning-based prediction of fractional flow reserve after percutaneous coronary intervention. Atherosclerosis. 2023 10; 383:117310.
Score: 0.009
-
Birnbaum Y, Chamoun AJ, Anzuini A, Lick SD, Ahmad M, Uretsky BF. Ventricular free wall rupture following acute myocardial infarction. Coron Artery Dis. 2003 Sep; 14(6):463-70.
Score: 0.009
-
Yang S, Hwang D, Zhang J, Park J, Yun JP, Lee JM, Nam CW, Shin ES, Doh JH, Chen SL, Kakuta T, Toth GG, Piroth Z, Johnson NP, Hakeem A, Uretsky BF, Hokama Y, Tanaka N, Lim HS, Ito T, Matsuo A, Azzalini L, Leesar MA, Neleman T, van Mieghem NM, Diletti R, Daemen J, Collison D, Collet C, De Bruyne B, Koo BK. Clinical and Vessel Characteristics Associated With Hard Outcomes After PCI and Their Combined Prognostic Implications. J Am Heart Assoc. 2023 09 05; 12(17):e030572.
Score: 0.009
-
Wang FW, Osman A, Otero J, Stouffer GA, Waxman S, Afzal A, Anzuini A, Uretsky BF. Distal myocardial protection during percutaneous coronary intervention with an intracoronary beta-blocker. Circulation. 2003 Jun 17; 107(23):2914-9.
Score: 0.009
-
Rempakos A, Kostantinis S, Simsek B, Karacsonyi J, Choi JW, Poommipanit P, Khatri JJ, Jaber W, Rinfret S, Nicholson W, Gorgulu S, Jaffer FA, Chandwaney R, Ybarra LF, Bagur R, Alaswad K, Krestyaninov O, Khelimskii D, Karmpaliotis D, Uretsky BF, Soylu K, Yildirim U, Potluri S, Al-Azizi KM, Rangan BV, Mastrodemos OC, Allana S, Sandoval Y, Burke MN, Brilakis ES. Procedural Time and Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention. Am J Cardiol. 2023 06 15; 197:55-64.
Score: 0.009
-
Rempakos A, Kostantinis S, Simsek B, Karacsonyi J, Choi JW, Poommipanit P, Khatri JJ, Jaber W, Rinfret S, Nicholson W, Gorgulu S, Jaffer FA, Chandwaney R, Ybarra LF, Bagur R, Alaswad K, Krestyaninov O, Khelimskii D, Karmpaliotis D, Uretsky BF, Soylu K, Yildirim U, Potluri S, Rangan BV, Mastrodemos OC, Allana S, Sandoval Y, Burke NM, Brilakis ES. Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention After a Previous Failed Attempt. Am J Cardiol. 2023 04 15; 193:61-69.
Score: 0.008
-
Karacsonyi J, Deffenbacher K, Benzuly KH, Flaherty JD, Alaswad K, Basir M, Megaly MS, Jaffer F, Doshi D, Poommipanit P, Khatri J, Patel M, Riley R, Sheikh A, Wollmuth JR, Korngold E, Uretsky BF, Yeh RW, Chandwaney RH, Elguindy AM, Tammam K, AbiRafeh N, Schmidt CW, Okeson B, Kostantinis S, Simsek B, Rangan BV, Brilakis ES, Schimmel DR. Use of Mechanical Circulatory Support in Chronic Total Occlusion Percutaneous Coronary Intervention. Am J Cardiol. 2023 02 15; 189:76-85.
Score: 0.008
-
Kostantinis S, Simsek B, Karacsonyi J, Alaswad K, Krestyaninov O, Khelimskii D, Karmpaliotis D, Jaffer FA, Khatri JJ, Poommipanit P, Choi JW, Jaber WA, Rinfret S, Nicholson W, Patel MP, Mahmud E, Dattilo P, Gorgulu S, Koutouzis M, Tsiafoutis I, Elbarouni B, Sheikh AM, Uretsky BF, ElGuindy AM, Jefferson BK, Patel TN, Wollmuth J, Riley RF, Benton SM, Davies RE, Chandwaney RH, Toma C, Yeh RW, Schimmel DR, Abi Rafeh N, Goktekin O, Kerrigan JL, Mastrodemos OC, Rangan BV, Garcia S, Sandoval Y, Burke MN, Brilakis E. In-hospital outcomes and temporal trends of percutaneous coronary interventions for chronic total occlusion. EuroIntervention. 2022 12 02; 18(11):e929-e932.
Score: 0.008
-
Wiley JM, White CJ, Uretsky BF. Noncoronary complications of coronary intervention. Catheter Cardiovasc Interv. 2002 Oct; 57(2):257-65.
Score: 0.008
-
Hwang D, Koo BK, Zhang J, Park J, Yang S, Kim M, Yun JP, Lee JM, Nam CW, Shin ES, Doh JH, Chen SL, Kakuta T, Toth GG, Piroth Z, Johnson NP, Pijls NHJ, Hakeem A, Uretsky BF, Hokama Y, Tanaka N, Lim HS, Ito T, Matsuo A, Azzalini L, Leesar MA, Neleman T, van Mieghem NM, Diletti R, Daemen J, Collison D, Collet C, De Bruyne B. Prognostic Implications of Fractional Flow Reserve After Coronary Stenting: A Systematic Review and Meta-analysis. JAMA Netw Open. 2022 09 01; 5(9):e2232842.
Score: 0.008
-
Erriquez A, Uretsky BF, Brugaletta S, Spitaleri G, Cerrato E, Quadri G, Manfrini M, Pompei G, Scancarello D, Trichilo M, Marchini F, Caglioni S, Campana R, Marrone A, Penzo C, Tumscitz C, Tebaldi M, Verardi FM, Scala A, Campo G, Biscaglia S. Impact of trans-stent gradient on outcome after PCI: results from a HAWKEYE substudy. Int J Cardiovasc Imaging. 2022 Dec; 38(12):2819-2827.
Score: 0.008
-
Elmer KM, Bean MJ, Uretsky BF, Stephens SE, Jensen HK, Jensen MO. Customizable Angioplasty Balloon-Forming Machine: Towards Precision Medicine in Coronary Bifurcation Lesion Interventions. J Cardiovasc Transl Res. 2022 10; 15(5):1119-1128.
Score: 0.008
-
Wang F, Stouffer GA, Waxman S, Uretsky BF. Late coronary stent thrombosis: early vs. late stent thrombosis in the stent era. Catheter Cardiovasc Interv. 2002 Feb; 55(2):142-7.
Score: 0.008
-
Triska J, Uretsky BF, Pitt B, Birnbaum Y. Closing the Digitalis Divide: Back to the Basics of Randomized Controlled Trials. Cardiovasc Drugs Ther. 2023 08; 37(4):807-813.
Score: 0.008
-
Xenogiannis I, Rangan BV, Uyeda L, Banerjee S, Edson R, Bhatt DL, Goldman S, Holmes DR, Rao SV, Shunk K, Mavromatis K, Ramanathan K, Bavry AA, McFalls EO, Garcia S, Thai H, Uretsky BF, Latif F, Armstrong E, Ortiz J, Jneid H, Liu J, Aggrawal K, Conner TA, Wagner T, Karacsonyi J, Ventura B, Alsleben A, Lu Y, Shih MC, Brilakis ES. In-Stent Restenosis in Saphenous Vein Grafts (from the DIVA Trial). Am J Cardiol. 2022 01 01; 162:24-30.
Score: 0.008
-
Nikolakopoulos I, Patel T, Jefferson BK, Sheikh AM, Jaber W, Samady H, Khatri JJ, Yeh RW, Tamez H, Koutouzis M, Tsiafoutis I, Jaffer FA, Doing AH, Dattilo P, Uretsky BF, Toma C, Elbarouni B, Alaswad K, Choi JW, Lembo NJ, Parikh M, Kirtane AJ, Ali ZA, Omer M, Vemmou E, Xenogiannis I, Karacsonyi J, Rangan BV, Abdullah S, Banerjee S, Garcia S, Burke MN, Brilakis ES, Karmpaliotis D. Distal Radial Access in Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From the PROGRESS-CTO Registry. J Invasive Cardiol. 2021 09; 33(9):E717-E722.
Score: 0.008
-
McGoogan KE, Haafiz AB, Gonz?lez Peralta RP. Herpes simplex virus hepatitis in infants: clinical outcomes and correlates of disease severity. J Pediatr. 2011 Oct; 159(4):608-11.
Score: 0.007
-
McGoogan KE, Haafiz AB, Gonz?lez Peralta RP. Herpes simplex virus hepatitis in infants: clinical outcomes and correlates of disease severity. J Pediatr. 2011 Oct; 159(4):608-11.
Score: 0.007
-
McGoogan KE, Haafiz AB, Gonz?lez Peralta RP. Herpes simplex virus hepatitis in infants: clinical outcomes and correlates of disease severity. J Pediatr. 2011 Oct; 159(4):608-11.
Score: 0.007
-
McGoogan KE, Haafiz AB, Gonz?lez Peralta RP. Herpes simplex virus hepatitis in infants: clinical outcomes and correlates of disease severity. J Pediatr. 2011 Oct; 159(4):608-11.
Score: 0.007
-
McGoogan KE, Haafiz AB, Gonz?lez Peralta RP. Herpes simplex virus hepatitis in infants: clinical outcomes and correlates of disease severity. J Pediatr. 2011 Oct; 159(4):608-11.
Score: 0.007
-
McGoogan KE, Haafiz AB, Gonz?lez Peralta RP. Herpes simplex virus hepatitis in infants: clinical outcomes and correlates of disease severity. J Pediatr. 2011 Oct; 159(4):608-11.
Score: 0.007
-
McGoogan KE, Haafiz AB, Gonz?lez Peralta RP. Herpes simplex virus hepatitis in infants: clinical outcomes and correlates of disease severity. J Pediatr. 2011 Oct; 159(4):608-11.
Score: 0.007
-
McGoogan KE, Haafiz AB, Gonz?lez Peralta RP. Herpes simplex virus hepatitis in infants: clinical outcomes and correlates of disease severity. J Pediatr. 2011 Oct; 159(4):608-11.
Score: 0.007
-
McGoogan KE, Haafiz AB, Gonz?lez Peralta RP. Herpes simplex virus hepatitis in infants: clinical outcomes and correlates of disease severity. J Pediatr. 2011 Oct; 159(4):608-11.
Score: 0.007
-
McGoogan KE, Haafiz AB, Gonz?lez Peralta RP. Herpes simplex virus hepatitis in infants: clinical outcomes and correlates of disease severity. J Pediatr. 2011 Oct; 159(4):608-11.
Score: 0.007
-
McGoogan KE, Haafiz AB, Gonz?lez Peralta RP. Herpes simplex virus hepatitis in infants: clinical outcomes and correlates of disease severity. J Pediatr. 2011 Oct; 159(4):608-11.
Score: 0.007
-
McGoogan KE, Haafiz AB, Gonz?lez Peralta RP. Herpes simplex virus hepatitis in infants: clinical outcomes and correlates of disease severity. J Pediatr. 2011 Oct; 159(4):608-11.
Score: 0.007
-
McGoogan KE, Haafiz AB, Gonz?lez Peralta RP. Herpes simplex virus hepatitis in infants: clinical outcomes and correlates of disease severity. J Pediatr. 2011 Oct; 159(4):608-11.
Score: 0.007
-
McGoogan KE, Haafiz AB, Gonz?lez Peralta RP. Herpes simplex virus hepatitis in infants: clinical outcomes and correlates of disease severity. J Pediatr. 2011 Oct; 159(4):608-11.
Score: 0.007
-
McGoogan KE, Haafiz AB, Gonz?lez Peralta RP. Herpes simplex virus hepatitis in infants: clinical outcomes and correlates of disease severity. J Pediatr. 2011 Oct; 159(4):608-11.
Score: 0.007
-
McGoogan KE, Haafiz AB, Gonz?lez Peralta RP. Herpes simplex virus hepatitis in infants: clinical outcomes and correlates of disease severity. J Pediatr. 2011 Oct; 159(4):608-11.
Score: 0.007
-
McGoogan KE, Haafiz AB, Gonz?lez Peralta RP. Herpes simplex virus hepatitis in infants: clinical outcomes and correlates of disease severity. J Pediatr. 2011 Oct; 159(4):608-11.
Score: 0.007
-
McGoogan KE, Haafiz AB, Gonz?lez Peralta RP. Herpes simplex virus hepatitis in infants: clinical outcomes and correlates of disease severity. J Pediatr. 2011 Oct; 159(4):608-11.
Score: 0.007
-
McGoogan KE, Haafiz AB, Gonz?lez Peralta RP. Herpes simplex virus hepatitis in infants: clinical outcomes and correlates of disease severity. J Pediatr. 2011 Oct; 159(4):608-11.
Score: 0.007
-
McGoogan KE, Haafiz AB, Gonz?lez Peralta RP. Herpes simplex virus hepatitis in infants: clinical outcomes and correlates of disease severity. J Pediatr. 2011 Oct; 159(4):608-11.
Score: 0.007
-
McGoogan KE, Haafiz AB, Gonz?lez Peralta RP. Herpes simplex virus hepatitis in infants: clinical outcomes and correlates of disease severity. J Pediatr. 2011 Oct; 159(4):608-11.
Score: 0.007
-
McGoogan KE, Haafiz AB, Gonz?lez Peralta RP. Herpes simplex virus hepatitis in infants: clinical outcomes and correlates of disease severity. J Pediatr. 2011 Oct; 159(4):608-11.
Score: 0.007
-
McGoogan KE, Haafiz AB, Gonz?lez Peralta RP. Herpes simplex virus hepatitis in infants: clinical outcomes and correlates of disease severity. J Pediatr. 2011 Oct; 159(4):608-11.
Score: 0.007
-
McGoogan KE, Haafiz AB, Gonz?lez Peralta RP. Herpes simplex virus hepatitis in infants: clinical outcomes and correlates of disease severity. J Pediatr. 2011 Oct; 159(4):608-11.
Score: 0.007
-
McGoogan KE, Haafiz AB, Gonz?lez Peralta RP. Herpes simplex virus hepatitis in infants: clinical outcomes and correlates of disease severity. J Pediatr. 2011 Oct; 159(4):608-11.
Score: 0.007
-
McGoogan KE, Haafiz AB, Gonz?lez Peralta RP. Herpes simplex virus hepatitis in infants: clinical outcomes and correlates of disease severity. J Pediatr. 2011 Oct; 159(4):608-11.
Score: 0.007
-
McGoogan KE, Haafiz AB, Gonz?lez Peralta RP. Herpes simplex virus hepatitis in infants: clinical outcomes and correlates of disease severity. J Pediatr. 2011 Oct; 159(4):608-11.
Score: 0.007
-
McGoogan KE, Haafiz AB, Gonz?lez Peralta RP. Herpes simplex virus hepatitis in infants: clinical outcomes and correlates of disease severity. J Pediatr. 2011 Oct; 159(4):608-11.
Score: 0.007
-
McGoogan KE, Haafiz AB, Gonz?lez Peralta RP. Herpes simplex virus hepatitis in infants: clinical outcomes and correlates of disease severity. J Pediatr. 2011 Oct; 159(4):608-11.
Score: 0.007
-
McGoogan KE, Haafiz AB, Gonz?lez Peralta RP. Herpes simplex virus hepatitis in infants: clinical outcomes and correlates of disease severity. J Pediatr. 2011 Oct; 159(4):608-11.
Score: 0.007
-
McGoogan KE, Haafiz AB, Gonz?lez Peralta RP. Herpes simplex virus hepatitis in infants: clinical outcomes and correlates of disease severity. J Pediatr. 2011 Oct; 159(4):608-11.
Score: 0.007
-
McGoogan KE, Haafiz AB, Gonz?lez Peralta RP. Herpes simplex virus hepatitis in infants: clinical outcomes and correlates of disease severity. J Pediatr. 2011 Oct; 159(4):608-11.
Score: 0.007
-
McGoogan KE, Haafiz AB, Gonz?lez Peralta RP. Herpes simplex virus hepatitis in infants: clinical outcomes and correlates of disease severity. J Pediatr. 2011 Oct; 159(4):608-11.
Score: 0.007
-
McGoogan KE, Haafiz AB, Gonz?lez Peralta RP. Herpes simplex virus hepatitis in infants: clinical outcomes and correlates of disease severity. J Pediatr. 2011 Oct; 159(4):608-11.
Score: 0.007
-
McGoogan KE, Haafiz AB, Gonz?lez Peralta RP. Herpes simplex virus hepatitis in infants: clinical outcomes and correlates of disease severity. J Pediatr. 2011 Oct; 159(4):608-11.
Score: 0.007
-
McGoogan KE, Haafiz AB, Gonz?lez Peralta RP. Herpes simplex virus hepatitis in infants: clinical outcomes and correlates of disease severity. J Pediatr. 2011 Oct; 159(4):608-11.
Score: 0.007
-
McGoogan KE, Haafiz AB, Gonz?lez Peralta RP. Herpes simplex virus hepatitis in infants: clinical outcomes and correlates of disease severity. J Pediatr. 2011 Oct; 159(4):608-11.
Score: 0.007
-
McGoogan KE, Haafiz AB, Gonz?lez Peralta RP. Herpes simplex virus hepatitis in infants: clinical outcomes and correlates of disease severity. J Pediatr. 2011 Oct; 159(4):608-11.
Score: 0.007
-
McGoogan KE, Haafiz AB, Gonz?lez Peralta RP. Herpes simplex virus hepatitis in infants: clinical outcomes and correlates of disease severity. J Pediatr. 2011 Oct; 159(4):608-11.
Score: 0.007
-
McGoogan KE, Haafiz AB, Gonz?lez Peralta RP. Herpes simplex virus hepatitis in infants: clinical outcomes and correlates of disease severity. J Pediatr. 2011 Oct; 159(4):608-11.
Score: 0.007
-
McGoogan KE, Haafiz AB, Gonz?lez Peralta RP. Herpes simplex virus hepatitis in infants: clinical outcomes and correlates of disease severity. J Pediatr. 2011 Oct; 159(4):608-11.
Score: 0.007
-
McGoogan KE, Haafiz AB, Gonz?lez Peralta RP. Herpes simplex virus hepatitis in infants: clinical outcomes and correlates of disease severity. J Pediatr. 2011 Oct; 159(4):608-11.
Score: 0.007
-
McGoogan KE, Haafiz AB, Gonz?lez Peralta RP. Herpes simplex virus hepatitis in infants: clinical outcomes and correlates of disease severity. J Pediatr. 2011 Oct; 159(4):608-11.
Score: 0.007
-
McGoogan KE, Haafiz AB, Gonz?lez Peralta RP. Herpes simplex virus hepatitis in infants: clinical outcomes and correlates of disease severity. J Pediatr. 2011 Oct; 159(4):608-11.
Score: 0.007
-
McGoogan KE, Haafiz AB, Gonz?lez Peralta RP. Herpes simplex virus hepatitis in infants: clinical outcomes and correlates of disease severity. J Pediatr. 2011 Oct; 159(4):608-11.
Score: 0.007
-
McGoogan KE, Haafiz AB, Gonz?lez Peralta RP. Herpes simplex virus hepatitis in infants: clinical outcomes and correlates of disease severity. J Pediatr. 2011 Oct; 159(4):608-11.
Score: 0.007
-
McGoogan KE, Haafiz AB, Gonz?lez Peralta RP. Herpes simplex virus hepatitis in infants: clinical outcomes and correlates of disease severity. J Pediatr. 2011 Oct; 159(4):608-11.
Score: 0.007
-
McGoogan KE, Haafiz AB, Gonz?lez Peralta RP. Herpes simplex virus hepatitis in infants: clinical outcomes and correlates of disease severity. J Pediatr. 2011 Oct; 159(4):608-11.
Score: 0.007
-
McGoogan KE, Haafiz AB, Gonz?lez Peralta RP. Herpes simplex virus hepatitis in infants: clinical outcomes and correlates of disease severity. J Pediatr. 2011 Oct; 159(4):608-11.
Score: 0.007
-
McGoogan KE, Haafiz AB, Gonz?lez Peralta RP. Herpes simplex virus hepatitis in infants: clinical outcomes and correlates of disease severity. J Pediatr. 2011 Oct; 159(4):608-11.
Score: 0.007
-
McGoogan KE, Haafiz AB, Gonz?lez Peralta RP. Herpes simplex virus hepatitis in infants: clinical outcomes and correlates of disease severity. J Pediatr. 2011 Oct; 159(4):608-11.
Score: 0.007
-
McGoogan KE, Haafiz AB, Gonz?lez Peralta RP. Herpes simplex virus hepatitis in infants: clinical outcomes and correlates of disease severity. J Pediatr. 2011 Oct; 159(4):608-11.
Score: 0.007
-
McGoogan KE, Haafiz AB, Gonz?lez Peralta RP. Herpes simplex virus hepatitis in infants: clinical outcomes and correlates of disease severity. J Pediatr. 2011 Oct; 159(4):608-11.
Score: 0.007
-
McGoogan KE, Haafiz AB, Gonz?lez Peralta RP. Herpes simplex virus hepatitis in infants: clinical outcomes and correlates of disease severity. J Pediatr. 2011 Oct; 159(4):608-11.
Score: 0.007
-
McGoogan KE, Haafiz AB, Gonz?lez Peralta RP. Herpes simplex virus hepatitis in infants: clinical outcomes and correlates of disease severity. J Pediatr. 2011 Oct; 159(4):608-11.
Score: 0.007
-
McGoogan KE, Haafiz AB, Gonz?lez Peralta RP. Herpes simplex virus hepatitis in infants: clinical outcomes and correlates of disease severity. J Pediatr. 2011 Oct; 159(4):608-11.
Score: 0.007
-
McGoogan KE, Haafiz AB, Gonz?lez Peralta RP. Herpes simplex virus hepatitis in infants: clinical outcomes and correlates of disease severity. J Pediatr. 2011 Oct; 159(4):608-11.
Score: 0.007
-
McGoogan KE, Haafiz AB, Gonz?lez Peralta RP. Herpes simplex virus hepatitis in infants: clinical outcomes and correlates of disease severity. J Pediatr. 2011 Oct; 159(4):608-11.
Score: 0.007
-
McGoogan KE, Haafiz AB, Gonz?lez Peralta RP. Herpes simplex virus hepatitis in infants: clinical outcomes and correlates of disease severity. J Pediatr. 2011 Oct; 159(4):608-11.
Score: 0.007
-
McGoogan KE, Haafiz AB, Gonz?lez Peralta RP. Herpes simplex virus hepatitis in infants: clinical outcomes and correlates of disease severity. J Pediatr. 2011 Oct; 159(4):608-11.
Score: 0.007
-
McGoogan KE, Haafiz AB, Gonz?lez Peralta RP. Herpes simplex virus hepatitis in infants: clinical outcomes and correlates of disease severity. J Pediatr. 2011 Oct; 159(4):608-11.
Score: 0.007
-
McGoogan KE, Haafiz AB, Gonz?lez Peralta RP. Herpes simplex virus hepatitis in infants: clinical outcomes and correlates of disease severity. J Pediatr. 2011 Oct; 159(4):608-11.
Score: 0.007
-
Biscaglia S, Uretsky BF, Tebaldi M, Erriquez A, Brugaletta S, Cerrato E, Quadri G, Spitaleri G, Colaiori I, Di Girolamo D, Scoccia A, Zucchetti O, D'Aniello E, Manfrini M, Pavasini R, Barbato E, Campo G. Angio-Based Fractional Flow Reserve, Functional Pattern of Coronary Artery Disease, and Prediction of Percutaneous Coronary Intervention Result: a Proof-of-Concept Study. Cardiovasc Drugs Ther. 2022 08; 36(4):645-653.
Score: 0.007
-
Xenogiannis I, Alaswad K, Krestyaninov O, Khelimskii D, Khatri JJ, Choi JW, Jaffer FA, Patel M, Mahmud E, Doing AH, Dattilo P, Koutouzis M, Tsiafoutis I, Uretsky B, Jefferson BK, Patel T, Jaber W, Samady H, Sheikh AM, Yeh RW, Tamez H, Elbarouni B, Love MP, Abi Rafeh N, Maalouf A, Fadi AJ, Toma C, Shah AR, Chandwaney RH, Omer M, Megaly MS, Vemmou E, Nikolakopoulos I, Rangan BV, Garcia S, Abdullah S, Banerjee S, Burke MN, Karmpaliotis D, Brilakis ES. Impact of adherence to the hybrid algorithm for initial crossing strategy selection in chronic total occlusion percutaneous coronary intervention. Rev Esp Cardiol (Engl Ed). 2021 Dec; 74(12):1023-1031.
Score: 0.007
-
Uretsky BF, Rosanio S, Lerakis S, Wang FW, Smiley M, Stouffer GA, Tocchi M, Estella P. A prospective evaluation of angiography-guided coronary stent implantation with high versus very high balloon inflation pressure. Am Heart J. 2000 Nov; 140(5):804-12.
Score: 0.007
-
Hassan A, Uretsky BF, Vargas Estrada AM, Hassan R, Al-Hawwas M, Agarwal SK. Systematic review of the evaluation and management of coronary pseudoaneurysm after stent implantation. Catheter Cardiovasc Interv. 2021 07 01; 98(1):107-116.
Score: 0.007
-
Azzalini L, Alaswad K, Uretsky BF, Agostoni P, Galassi AR, Harada Ribeiro M, Filho EM, Morales-Victorino N, Attallah A, Gupta A, Zivelonghi C, Montorfano M, Bellini B, Carlino M. Multicenter experience with the antegrade fenestration and reentry technique for chronic total occlusion recanalization. Catheter Cardiovasc Interv. 2021 01 01; 97(1):E40-E50.
Score: 0.007
-
Xenogiannis I, Gkargkoulas F, Karmpaliotis D, Alaswad K, Jaffer FA, Yeh RW, Patel M, Mahmud E, Choi JW, Burke MN, Garcia S, Doing AH, Dattilo P, Toma C, Uretsky B, Krestyaninov O, Khelimskii D, Moses JW, Lembo NJ, Parikh M, Kirtane AJ, Ali ZA, Russo JJ, Hakemi E, Hall AB, Nikolakopoulos I, Vemmou E, Karatasakis A, Danek B, Rangan BV, Abdullah S, Banerjee S, Brilakis ES. Temporal Trends in Chronic Total Occlusion Percutaneous Coronary Interventions: Insights From the PROGRESS-CTO Registry. J Invasive Cardiol. 2020 04; 32(4):153-160.
Score: 0.007
-
Azzalini L, Tzanis G, Mashayekhi K, Uretsky BF, Ojeda S, Pan M, Rinfret S, Avran A, Alaswad K, Yamane M, Karmpaliotis D, Brilakis ES, Carlino M, Ybarra LF. Solving Challenging Situations and Complications in Everyday Percutaneous Coronary Intervention Using Chronic Total Occlusion Techniques. J Invasive Cardiol. 2020 03; 32(3):E63-E72.
Score: 0.007
-
Latif F, Uyeda L, Edson R, Bhatt DL, Goldman S, Holmes DR, Rao SV, Shunk K, Aggarwal K, Uretsky B, Bolad I, Ziada K, McFalls E, Irimpen A, Truong HT, Kinlay S, Papademetriou V, Velagaleti RS, Rangan BV, Mavromatis K, Shih MC, Banerjee S, Brilakis ES. Stent-Only Versus Adjunctive Balloon Angioplasty Approach for Saphenous Vein Graft Percutaneous Coronary Intervention: Insights From DIVA Trial. Circ Cardiovasc Interv. 2020 02; 13(2):e008494.
Score: 0.007
-
Xenogiannis I, Gkargkoulas F, Karmpaliotis D, Alaswad K, Krestyaninov O, Khelimskii D, Choi JW, Jaffer FA, Patel M, Mahmud E, Khatri JJ, Kandzari DE, Doing AH, Dattilo P, Toma C, Koutouzis M, Tsiafoutis I, Uretsky B, Yeh RW, Tamez H, Wyman RM, Jefferson BK, Patel T, Jaber W, Samady H, Sheikh AM, Malik BA, Holper E, Potluri S, Moses JW, Lembo NJ, Parikh M, Kirtane AJ, Ali ZA, Hall AB, Vemmou E, Nikolakopoulos I, Dargham BB, Rangan BV, Abdullah S, Garcia S, Banerjee S, Burke MN, Brilakis ES. The Impact of Peripheral Artery Disease in Chronic Total Occlusion Percutaneous Coronary Intervention (Insights From PROGRESS-CTO Registry). Angiology. 2020 03; 71(3):274-280.
Score: 0.007
-
Xenogiannis I, Choi JW, Alaswad K, Khatri JJ, Doing AH, Dattilo P, Jaffer FA, Uretsky B, Krestyaninov O, Khelimskii D, Patel M, Mahmud E, Potluri S, Koutouzis M, Tsiafoutis I, Jaber W, Samady H, Jefferson BK, Patel T, Megaly MS, Hall AB, Vemmou E, Nikolakopoulos I, Rangan BV, Abdullah S, Garcia S, Banerjee S, Burke MN, Brilakis ES. Outcomes of subintimal plaque modification in chronic total occlusion percutaneous coronary intervention. Catheter Cardiovasc Interv. 2020 11; 96(5):1029-1035.
Score: 0.007
-
Xenogiannis I, Karmpaliotis D, Alaswad K, Jaffer FA, Yeh RW, Patel M, Mahmud E, Choi JW, Burke MN, Doing AH, Dattilo P, Toma C, Uretsky B, Krestyaninov O, Khelimskii D, Holper E, Potluri S, Wyman RM, Kandzari DE, Garcia S, Koutouzis M, Tsiafoutis I, Khatri JJ, Jaber W, Samady H, Jefferson BK, Patel T, Moses JW, Lembo NJ, Parikh M, Kirtane AJ, Ali ZA, Gkargkoulas F, Tajti P, Hall AB, Rangan BV, Abdullah S, Banerjee S, Brilakis ES. Impact of concomitant treatment of non-chronic total occlusion lesions at the time of chronic total occlusion intervention. Int J Cardiol. 2020 01 15; 299:75-80.
Score: 0.007
-
Uretsky BF, Runge MS. Unstable angina. Introduction. Cardiol Clin. 1999 May; 17(2):xiii-xvii.
Score: 0.006
-
Tajti P, Karmpaliotis D, Alaswad K, Jaffer FA, Yeh RW, Patel M, Mahmud E, Choi JW, Burke MN, Doing AH, Dattilo P, Toma C, Smith AJC, Uretsky B, Holper E, Potluri S, Wyman RM, Kandzari DE, Garcia S, Krestyaninov O, Khelimskii D, Koutouzis M, Tsiafoutis I, Jaber W, Samady H, Moses JW, Lembo NJ, Parikh M, Kirtane AJ, Ali ZA, Doshi D, Xenogiannis I, Stanberry LI, Rangan BV, Ungi I, Banerjee S, Brilakis ES. In-Hospital Outcomes of Chronic Total Occlusion Percutaneous Coronary Interventions in Patients With Prior Coronary Artery Bypass Graft Surgery. Circ Cardiovasc Interv. 2019 03; 12(3):e007338.
Score: 0.006
-
Tajti P, Alaswad K, Karmpaliotis D, Jaffer FA, Yeh RW, Patel M, Mahmud E, Choi JW, Burke MN, Doing AH, Dattilo P, Toma C, Smith AJC, Uretsky BF, Holper E, Potluri S, Wyman RM, Kandzari DE, Garcia S, Krestyaninov O, Khelimskii D, Koutouzis M, Tsiafoutis I, Khatri JJ, Jaber W, Samady H, Jefferson B, Patel T, Abdullah S, Moses JW, Lembo NJ, Parikh M, Kirtane AJ, Ali ZA, Doshi D, Xenogiannis I, Stanberry LI, Rangan BV, Ungi I, Banerjee S, Brilakis ES. Procedural Outcomes of Percutaneous Coronary Interventions for Chronic Total Occlusions Via the Radial Approach: Insights From an International Chronic Total Occlusion Registry. JACC Cardiovasc Interv. 2019 02 25; 12(4):346-358.
Score: 0.006
-
Sandoval Y, Tajti P, Karatasakis A, Burke MN, Danek BA, Karmpaliotis D, Alaswad K, Jaffer FA, Yeh RW, Patel M, Mahmud E, Krestyaninov O, Khelimskii D, Choi JW, Doing AH, Toma C, Wyman RM, Uretsky B, Garcia S, Koutouzis M, Tsiafoutis I, Holper E, Moses JW, Lembo NJ, Parikh M, Kirtane AJ, Ali ZA, Doshi D, Kandzari DE, Karacsonyi J, Rangan BV, Thompson C, Banerjee S, Brilakis ES. Frequency and Outcomes of Ad Hoc Versus Planned Chronic Total Occlusion Percutaneous Coronary Intervention: Multicenter Experience. J Invasive Cardiol. 2019 05; 31(5):133-139.
Score: 0.006
-
Tajti P, Karatasakis A, Danek BA, Alaswad K, Karmpaliotis D, Jaffer FA, Choi JW, Yeh RW, Patel M, Mahmud E, Burke MN, Krestyaninov O, Khelimskii D, Toma C, Doing AH, Uretsky B, Koutouzis M, Tsiafoutis I, Wyman RM, Garcia S, Holper E, Xenogiannis I, Rangan BV, Banerjee S, Ungi I, Brilakis ES. In-Hospital Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention in Patients With Chronic Kidney Disease. J Invasive Cardiol. 2018 11; 30(11):E113-E121.
Score: 0.006
-
Tajti P, Burke MN, Karmpaliotis D, Alaswad K, Jaffer FA, Yeh RW, Patel M, Mahmud E, Choi JW, Doing AH, Datilo P, Toma C, Smith AJC, Uretsky B, Holper E, Garcia S, Krestyaninov O, Khelimskii D, Koutouzis M, Tsiafoutis I, Moses JW, Lembo NJ, Parikh M, Kirtane AJ, Ali ZA, Doshi D, Jaber W, Samady H, Rangan BV, Xenogiannis I, Ungi I, Banerjee S, Brilakis ES. Prevalence and Outcomes of Percutaneous Coronary Interventions for Ostial Chronic Total Occlusions: Insights From a Multicenter Chronic Total Occlusion Registry. Can J Cardiol. 2018 10; 34(10):1264-1274.
Score: 0.006
-
Almomani A, Pothineni NV, Edupuganti M, Payne J, Agarwal S, Uretsky B, Hakeem A. Outcomes of Fractional Flow Reserve-Based Deferral in Saphenous Vein Graft Narrowing. Am J Cardiol. 2018 09 01; 122(5):723-728.
Score: 0.006
-
Saad M, Bavineni M, Uretsky BF, Vallurupalli S. Improved stent expansion with prolonged compared with short balloon inflation: A meta-analysis. Catheter Cardiovasc Interv. 2018 11 01; 92(5):873-880.
Score: 0.006
-
Tajti P, Alaswad K, Karmpaliotis D, Jaffer FA, Yeh RW, Patel M, Mahmud E, Choi JW, Burke MN, Doing AH, Toma C, Uretsky B, Holper E, Wyman RM, Kandzari DE, Garcia S, Krestyaninov O, Khelimskii D, Koutouzis M, Tsiafoutis I, Jaber W, Samady H, Moses JW, Lembo NJ, Parikh M, Kirtane AJ, Ali ZA, Doshi D, Xenogiannis I, Rangan BV, Ungi I, Banerjee S, Brilakis ES. In-hospital Outcomes of Attempting More Than One Chronic Total Coronary Occlusion Through Percutaneous Intervention During the Same Procedure. Am J Cardiol. 2018 08 01; 122(3):381-387.
Score: 0.006
-
Runge MS, Stouffer GA, Sheahan RG, Uretsky BF. Perspectives on coronary stenting. Am J Med Sci. 1998 May; 315(5):322-6.
Score: 0.006
-
Tajti P, Karmpaliotis D, Alaswad K, Jaffer FA, Yeh RW, Patel M, Mahmud E, Choi JW, Burke MN, Doing AH, Dattilo P, Toma C, Smith AJC, Uretsky B, Holper E, Wyman RM, Kandzari DE, Garcia S, Krestyaninov O, Khelimskii D, Koutouzis M, Tsiafoutis I, Moses JW, Lembo NJ, Parikh M, Kirtane AJ, Ali ZA, Doshi D, Rangan BV, Ungi I, Banerjee S, Brilakis ES. The Hybrid Approach to Chronic?Total?Occlusion Percutaneous?Coronary?Intervention: Update From the PROGRESS CTO Registry. JACC Cardiovasc Interv. 2018 07 23; 11(14):1325-1335.
Score: 0.006
-
Pothineni NVK, Edupuganti MM, Almomani A, Payne J, Raina S, Fnu S, Abualsuod A, Wong J, Uretsky BF, Hakeem A. Comparison of the prognostic value of non-ischaemic fractional flow reserve using intracoronary versus intravenous adenosine. EuroIntervention. 2018 02 20; 13(14):1680-1687.
Score: 0.006
-
Tajti P, Karmpaliotis D, Alaswad K, Toma C, Choi JW, Jaffer FA, Doing AH, Patel M, Mahmud E, Uretsky B, Karatasakis A, Karacsonyi J, Danek BA, Rangan BV, Banerjee S, Ungi I, Brilakis ES. Prevalence, Presentation and Treatment of 'Balloon Undilatable' Chronic Total Occlusions: Insights from a Multicenter US Registry. Catheter Cardiovasc Interv. 2018 03 01; 91(4):657-666.
Score: 0.006
-
Uretsky BF, Sheahan RG. Primary prevention of sudden cardiac death in heart failure: will the solution be shocking? J Am Coll Cardiol. 1997 Dec; 30(7):1589-97.
Score: 0.006
-
Stouffer GA, Uretsky BF. Hemodynamic changes of aortic regurgitation. Am J Med Sci. 1997 Dec; 314(6):411-4.
Score: 0.006
-
Lerakis S, Cutler D, Zhao D, Conti VR, Uretsky BF. Relation of unstable angina and myocardial infarction to progression of coronary narrowing in patients undergoing coronary artery bypass grafting (utilizing an internal mammary artery). Am J Cardiol. 1997 Jun 15; 79(12):1683-5.
Score: 0.006
-
Karacsonyi J, Karmpaliotis D, Alaswad K, Jaffer FA, Yeh RW, Patel M, Mahmud E, Doing A, Toma C, Uretsky B, Choi J, Moses JW, Kirtane A, Parikh M, Ali Z, Lombardi WL, Kandzari DE, Lembo N, Garcia S, Wyman MR, Martinez-Parachini JR, Karatasakis A, Danek BA, Alame AJ, Resendes E, Rangan BV, Ungi I, Thompson CA, Banerjee S, Brilakis ES. The Impact of Proximal Vessel Tortuosity on the Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From a Contemporary Multicenter Registry. J Invasive Cardiol. 2017 Aug; 29(8):264-270.
Score: 0.006
-
Parmar RJ, Uretsky BF. Obliteration of a coronary artery aneurysm with percutaneous transluminal coronary angioplasty and stent placement. Cathet Cardiovasc Diagn. 1997 May; 41(1):51-2.
Score: 0.006
-
Azzalini L, Carlino M, Brilakis ES, Vo M, Rinfret S, Uretsky BF, Karmpaliotis D, Colombo A. Subadventitial techniques for chronic total occlusion percutaneous coronary intervention: The concept of "vessel architecture". Catheter Cardiovasc Interv. 2018 03 01; 91(4):725-734.
Score: 0.006
-
Kasula S, Agarwal SK, Hacioglu Y, Pothineni NK, Bhatti S, Ahmed Z, Uretsky B, Hakeem A. Clinical and prognostic value of poststenting fractional flow reserve in acute coronary syndromes. Heart. 2016 12 15; 102(24):1988-1994.
Score: 0.005
-
Agarwal SK, Kasula S, Hacioglu Y, Ahmed Z, Uretsky BF, Hakeem A. Utilizing Post-Intervention Fractional Flow Reserve to Optimize Acute Results and the Relationship to Long-Term Outcomes. JACC Cardiovasc Interv. 2016 05 23; 9(10):1022-31.
Score: 0.005
-
MacGowan GA, Murali S, Loftus S, Uretsky BF. Comparison of metabolic, ventilatory, and neurohumoral responses during light forearm isometric exercise and isotonic exercise in congestive heart failure. Am J Cardiol. 1996 Feb 15; 77(5):391-6.
Score: 0.005
-
Carlino M, Ruparelia N, Thomas G, Brooks M, Uretsky BF, Brilakis ES, Karmpaliotis D, Hanratty C, Walsh S, Spratt J, Colombo A. Modified contrast microinjection technique to facilitate chronic total occlusion recanalization. Catheter Cardiovasc Interv. 2016 May; 87(6):1036-41.
Score: 0.005
-
Carlino M, Figini F, Ruparelia N, Uretsky BF, Godino C, Latib A, Bertoldi L, Brilakis E, Karmpaliotis D, Antoniucci D, Margonato A, Colombo A. Predictors of restenosis following contemporary subintimal tracking and reentry technique: The importance of final TIMI flow grade. Catheter Cardiovasc Interv. 2016 Apr; 87(5):884-92.
Score: 0.005
-
Ward RE, Gheorghiade M, Young JB, Uretsky B. Economic outcomes of withdrawal of digoxin therapy in adult patients with stable congestive heart failure. J Am Coll Cardiol. 1995 Jul; 26(1):93-101.
Score: 0.005
-
Agarwal SK, Vallurupalli S, Uretsky BF, Hakeem A. Effectiveness of colchicine for the prevention of recurrent pericarditis and post-pericardiotomy syndrome: an updated meta-analysis of randomized clinical data. Eur Heart J Cardiovasc Pharmacother. 2015 Apr; 1(2):117-25.
Score: 0.005
-
Fleisher LA, Fleischmann KE, Auerbach AD, Barnason SA, Beckman JA, Bozkurt B, Davila-Roman VG, Gerhard-Herman MD, Holly TA, Kane GC, Marine JE, Nelson MT, Spencer CC, Thompson A, Ting HH, Uretsky BF, Wijeysundera DN. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. Developed in collaboration with the American College of Surgeons, American Society of Anesthesiologists, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Anesthesiologists, and Society of Vascular Medicine Endorsed by the Society of Hospital Medicine. J Nucl Cardiol. 2015 Feb; 22(1):162-215.
Score: 0.005
-
Uretsky BF, Denys BG, Counihan PC, Ragosta M. Angioscopic evaluation of incompletely obstructing coronary intraluminal filling defects: comparison to angiography. Cathet Cardiovasc Diagn. 1994 Dec; 33(4):323-9.
Score: 0.005
-
Rosenbaum AM, Murali S, Uretsky BF. Intra-aortic balloon counterpulsation as a 'bridge' to cardiac transplantation. Effects in nonischemic and ischemic cardiomyopathy. Chest. 1994 Dec; 106(6):1683-8.
Score: 0.005
-
Carell ES, Murali S, Schulman DS, Estrada-Quintero T, Uretsky BF. Maximal exercise tolerance in chronic congestive heart failure. Relationship to resting left ventricular function. Chest. 1994 Dec; 106(6):1746-52.
Score: 0.005
-
Carlino M, Magri CJ, Uretsky BF, Brilakis ES, Walsh S, Spratt JC, Hanratty C, Grantham JA, Rinfret S, Thompson CA, Lombardi WL, Galassi AR, Sianos G, Latib A, Garbo R, Karmpaliotis D, Kandzari DE, Colombo A. Treatment of the chronic total occlusion: a call to action for the interventional community. Catheter Cardiovasc Interv. 2015 Apr; 85(5):771-8.
Score: 0.005
-
Fleisher LA, Fleischmann KE, Auerbach AD, Barnason SA, Beckman JA, Bozkurt B, Davila-Roman VG, Gerhard-Herman MD, Holly TA, Kane GC, Marine JE, Nelson MT, Spencer CC, Thompson A, Ting HH, Uretsky BF, Wijeysundera DN. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014 Dec 09; 130(24):e278-333.
Score: 0.005
-
Fleisher LA, Fleischmann KE, Auerbach AD, Barnason SA, Beckman JA, Bozkurt B, Davila-Roman VG, Gerhard-Herman MD, Holly TA, Kane GC, Marine JE, Nelson MT, Spencer CC, Thompson A, Ting HH, Uretsky BF, Wijeysundera DN. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol. 2014 Dec 09; 64(22):e77-137.
Score: 0.005
-
Mallikarjuna Rao Edupuganti M, Marmagkiolis K, Cilingiroglu M, Uretsky BF, Hakeem A. Optimizing selection of antithrombotic therapy in patients requiring PCI and long term anticoagulation. Cardiovasc Revasc Med. 2014 Nov-Dec; 15(8):414-20.
Score: 0.005
-
Brilakis ES, Karmpaliotis D, Werner GS, Spratt JC, Uretsky BF, Luna M, Banerjee S. Developments in coronary chronic total occlusion percutaneous coronary interventions: 2014 state-of-the-art update. J Invasive Cardiol. 2014 Jun; 26(6):261-6.
Score: 0.005
-
Uretsky BF, Young JB, Shahidi FE, Yellen LG, Harrison MC, Jolly MK. Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial. PROVED Investigative Group. J Am Coll Cardiol. 1993 Oct; 22(4):955-62.
Score: 0.004
-
Young JB, Winters WL, Bourge R, Uretsky BF. 24th Bethesda conference: Cardiac transplantation. Task Force 4: Function of the heart transplant recipient. J Am Coll Cardiol. 1993 Jul; 22(1):31-41.
Score: 0.004
-
Schulman DS, Herman BA, Edwards T, Ziady G, Uretsky BF. Effect on verapamil on ventricular function: studies in denervated human heart. J Cardiovasc Pharmacol. 1993 Apr; 21(4):567-72.
Score: 0.004
-
Rifkin RD, Uretsky BF. Screening for latent coronary artery disease by fluoroscopic detection of calcium in the coronary arteries. Am J Cardiol. 1993 Feb 15; 71(5):434-6.
Score: 0.004
-
Schulman DS, Herman BA, Edwards TD, Ziady G, Uretsky BF. Diastolic dysfunction in cardiac transplant recipients: an important role in the response to increased afterload. Am Heart J. 1993 Feb; 125(2 Pt 1):435-42.
Score: 0.004
-
Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, Thygesen K, Alpert JS, White HD, Jaffe AS, Katus HA, Apple FS, Lindahl B, Morrow DA, Chaitman BR, Clemmensen PM, Johanson P, Hod H, Underwood R, Bax JJ, Bonow JJ, Pinto F, Gibbons RJ, Fox KA, Atar D, Newby LK, Galvani M, Hamm CW, Uretsky BF, Steg PG, Wijns W, Bassand JP, Menasche P, Ravkilde J, Ohman EM, Antman EM, Wallentin LC, Armstrong PW, Simoons ML, Januzzi JL, Nieminen MS, Gheorghiade M, Filippatos G, Luepker RV, Fortmann SP, Rosamond WD, Levy D, Wood D, Smith SC, Hu D, Lopez-Sendon JL, Robertson RM, Weaver D, Tendera M, Bove AA, Parkhomenko AN, Vasilieva EJ, Mendis S, Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S, Morais J, Aguiar C, Almahmeed W, Arnar DO, Barili F, Bloch KD, Bolger AF, Botker HE, Bozkurt B, Bugiardini R, Cannon C, de Lemos J, Eberli FR, Escobar E, Hlatky M, James S, Kern KB, Moliterno DJ, Mueller C, Neskovic AN, Pieske BM, Schulman SP, Storey RF, Taubert KA, Vranckx P, Wagner DR. Third universal definition of myocardial infarction. J Am Coll Cardiol. 2012 Oct 16; 60(16):1581-98.
Score: 0.004
-
O'Connell JB, Bourge RC, Costanzo-Nordin MR, Driscoll DJ, Morgan JP, Rose EA, Uretsky BF. Cardiac transplantation: recipient selection, donor procurement, and medical follow-up. A statement for health professionals from the Committee on Cardiac Transplantation of the Council on Clinical Cardiology, American Heart Association. Circulation. 1992 Sep; 86(3):1061-79.
Score: 0.004
-
Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, Katus HA, Lindahl B, Morrow DA, Clemmensen PM, Johanson P, Hod H, Underwood R, Bax JJ, Bonow RO, Pinto F, Gibbons RJ, Fox KA, Atar D, Newby LK, Galvani M, Hamm CW, Uretsky BF, Steg PG, Wijns W, Bassand JP, Menasch? P, Ravkilde J, Ohman EM, Antman EM, Wallentin LC, Armstrong PW, Simoons ML, Januzzi JL, Nieminen MS, Gheorghiade M, Filippatos G, Luepker RV, Fortmann SP, Rosamond WD, Levy D, Wood D, Smith SC, Hu D, Lopez-Sendon JL, Robertson RM, Weaver D, Tendera M, Bove AA, Parkhomenko AN, Vasilieva EJ, Mendis S. Third universal definition of myocardial infarction. Circulation. 2012 Oct 16; 126(16):2020-35.
Score: 0.004
-
Aleti S, Uretsky BF, Sachdeva R. Utility of fractional flow reserve to determine treatment after recent large myocardial infarction with severe left ventricular dysfunction. Catheter Cardiovasc Interv. 2012 Nov 01; 80(5):830-4.
Score: 0.004
-
Uretsky BF. Sensory reinnervation of the heart after cardiac transplantation. N Engl J Med. 1992 Jan 02; 326(1):66-7; author reply 67-8.
Score: 0.004
-
Prayaga S, Uretsky BF, Sachdeva R. ST-elevation myocardial infarction as a complication of retrograde chronic total occlusion recanalization. Catheter Cardiovasc Interv. 2012 Oct 01; 80(4):611-5.
Score: 0.004
-
Kalaga R, Uretsky BF, Sachdeva R. Atresia of the left internal mammary artery graft following percutaneous intervention of the left main. J Invasive Cardiol. 2011 Dec; 23(12):E284-7.
Score: 0.004
-
Uretsky BF, Hua J. Combined intravenous pharmacotherapy in the treatment of patients with decompensated congestive heart failure. Am Heart J. 1991 Jun; 121(6 Pt 1):1879-86.
Score: 0.004
-
Klein LW, Ho KK, Singh M, Anderson HV, Hillegass WB, Uretsky BF, Chambers C, Rao SV, Reilly J, Weiner BH, Kern M, Bailey S. Quality assessment and improvement in interventional cardiology: a Position Statement of the Society of Cardiovascular Angiography and Interventions, Part II: public reporting and risk adjustment. Catheter Cardiovasc Interv. 2011 Oct 01; 78(4):493-502.
Score: 0.004
-
Aleti S, Bansal D, Agrawal M, Uretsky BF, Sachdeva R. Effect of chronic angiotensin converting enzyme inhibitor therapy on myocardial injury in patients undergoing percutaneous coronary interventions. J Invasive Cardiol. 2011 Feb; 23(2):72-5.
Score: 0.004
-
Reddy PS, Curtiss EI, Uretsky BF. Spectrum of hemodynamic changes in cardiac tamponade. Am J Cardiol. 1990 Dec 15; 66(20):1487-91.
Score: 0.004
-
Uretsky BF, Jessup M, Konstam MA, Dec GW, Leier CV, Benotti J, Murali S, Herrmann HC, Sandberg JA. Multicenter trial of oral enoximone in patients with moderate to moderately severe congestive heart failure. Lack of benefit compared with placebo. Enoximone Multicenter Trial Group. Circulation. 1990 Sep; 82(3):774-80.
Score: 0.004
-
Uretsky BF, Verbalis JG, Murali S, Betschart AR, Kolesar JA, Reddy PS. Control of atrial natriuretic peptide secretion in patients with severe congestive heart failure. J Clin Endocrinol Metab. 1990 Jul; 71(1):146-51.
Score: 0.003
-
Huang MH, Lui CY, Abusaid GH, Poh KK, Barbagelata AN, Uretsky BF, Fujise K. Cardiac calcitonin gene-related peptide and left ventricular hypertrophy in the cardiac allograft. J Heart Lung Transplant. 2010 Apr; 29(4):487-8.
Score: 0.003
-
Klein LW, Sheldon MW, Brinker J, Mixon TA, Skelding K, Strunk AO, Tommaso CL, Weiner B, Bailey SR, Uretsky B, Kern M, Laskey W. The use of radiographic contrast media during PCI: a focused review: a position statement of the Society of Cardiovascular Angiography and Interventions. Catheter Cardiovasc Interv. 2009 Nov 01; 74(5):728-46.
Score: 0.003
-
Denys BG, Reddy PS, Uretsky BF. Nephrotoxicity of a nonionic (iopamidol) versus an ionic (diatrizoate) contrast agent in the patient after cardiac transplant with moderate cyclosporine-induced renal insufficiency. Am J Cardiol. 1989 Aug 01; 64(5):405-6.
Score: 0.003
-
Huang MH, Nguyen V, Wu Y, Rastogi S, Lui CY, Birnbaum Y, Wang HQ, Ware DL, Chauhan M, Garg N, Poh KK, Ye L, Omar AR, Tan HC, Uretsky BF, Fujise K. Reducing ischaemia/reperfusion injury through delta-opioid-regulated intrinsic cardiac adrenergic cells: adrenopeptidergic co-signalling. Cardiovasc Res. 2009 Dec 01; 84(3):452-60.
Score: 0.003
-
Uretsky BF, Shaver JA, Liang CS, Amin D, Shah PK, Levine TB, Walinsky P, LeJemtel T, Linnemaier T. Lisinopril for severe congestive heart failure. Am J Cardiol. 1989 Feb 21; 63(8):8D-11D.
Score: 0.003
-
Uretsky BF, Shaver JA, Liang CS, Amin D, Shah PK, Levine TB, Walinsky P, LeJemtel T, Linnemeier T, Rush JE, et al. Modulation of hemodynamic effects with a converting enzyme inhibitor: acute hemodynamic dose-response relationship of a new angiotensin converting enzyme inhibitor, lisinopril, with observations on long-term clinical, functional, and biochemical responses. Am Heart J. 1988 Aug; 116(2 Pt 1):480-8.
Score: 0.003
-
Uretsky BF, Rifkin RD, Sharma SC, Reddy PS. Value of fluoroscopy in the detection of coronary stenosis: influence of age, sex, and number of vessels calcified on diagnostic efficacy. Am Heart J. 1988 Feb; 115(2):323-33.
Score: 0.003
-
Budoff MJ, Achenbach S, Berman DS, Fayad ZA, Poon M, Taylor AJ, Uretsky BF, Williams KA. Task force 13: training in advanced cardiovascular imaging (computed tomography). J Cardiovasc Comput Tomogr. 2008 Mar-Apr; 2(2):130-5.
Score: 0.003
-
Thygesen K, Alpert JS, White HD, Jaffe AS, Apple FS, Galvani M, Katus HA, Newby LK, Ravkilde J, Chaitman B, Clemmensen PM, Dellborg M, Hod H, Porela P, Underwood R, Bax JJ, Beller GA, Bonow R, Van der Wall EE, Bassand JP, Wijns W, Ferguson TB, Steg PG, Uretsky BF, Williams DO, Armstrong PW, Antman EM, Fox KA, Hamm CW, Ohman EM, Simoons ML, Poole-Wilson PA, Gurfinkel EP, Lopez-Sendon JL, Pais P, Mendis S, Zhu JR, Wallentin LC, Fern?ndez-Avil?s F, Fox KM, Parkhomenko AN, Priori SG, Tendera M, Voipio-Pulkki LM, Vahanian A, Camm AJ, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Morais J, Brener S, Harrington R, Morrow D, Lim M, Martinez-Rios MA, Steinhubl S, Levine GN, Gibler WB, Goff D, Tubaro M, Dudek D, Al-Attar N. Universal definition of myocardial infarction. Circulation. 2007 Nov 27; 116(22):2634-53.
Score: 0.003
-
Uretsky BF, Murali S, Reddy PS, Rabin B, Lee A, Griffith BP, Hardesty RL, Trento A, Bahnson HT. Development of coronary artery disease in cardiac transplant patients receiving immunosuppressive therapy with cyclosporine and prednisone. Circulation. 1987 Oct; 76(4):827-34.
Score: 0.003
-
Uretsky BF, Lawless CE, Verbalis JG, Valdes AM, Kolesar JA, Reddy PS. Combined therapy with dobutamine and amrinone in severe heart failure. Improved hemodynamics and increased activation of the renin-angiotensin system with combined intravenous therapy. Chest. 1987 Oct; 92(4):657-62.
Score: 0.003
-
Garg R, Uretsky BF, Lev EI. Anti-platelet and anti-thrombotic approaches in patients undergoing percutaneous coronary intervention. Catheter Cardiovasc Interv. 2007 Sep; 70(3):388-406.
Score: 0.003
-
Merla R, Reddy NK, Wang FW, Uretsky BF, Barbagelata A, Birnbaum Y. Meta-analysis of published reports on the effect of statin treatment before percutaneous coronary intervention on periprocedural myonecrosis. Am J Cardiol. 2007 Sep 01; 100(5):770-6.
Score: 0.003
-
Salinas G, Rangasetty UC, Uretsky BF, Birnbaum Y. The cycloxygenase 2 (COX-2) story: it's time to explain, not inflame. J Cardiovasc Pharmacol Ther. 2007 Jun; 12(2):98-111.
Score: 0.003
-
Dehmer GJ, Babb JD, Uretsky BF, Seth A. SCAI: Going global. Catheter Cardiovasc Interv. 2007 Apr 01; 69(5):768-72.
Score: 0.003
-
Dehmer GJ, Blankenship J, Wharton TP, Seth A, Morrison DA, Dimario C, Muller D, Kellett M, Uretsky BF. The current status and future direction of percutaneous coronary intervention without on-site surgical backup: an expert consensus document from the Society for Cardiovascular Angiography and Interventions. Catheter Cardiovasc Interv. 2007 Mar 01; 69(4):471-8.
Score: 0.003
-
McGehee JT, Rangasetty UC, Atar S, Barbagelata NN, Uretsky BF, Birnbaum Y. Grade 3 ischemia on admission electrocardiogram and chest pain duration predict failure of ST-segment resolution after primary percutaneous coronary intervention for acute myocardial infarction. J Electrocardiol. 2007 Jan; 40(1):26-33.
Score: 0.003
-
Saeed M, Rahman A, Afzal A, Agoston I, Jammula P, Birnbaum Y, Ware DL, Uretsky BF, Schwarz ER, Rosanio S. Role of transesophageal echocardiography guided cardioversion in patients with atrial fibrillation, previous left atrial thrombus and effective anticoagulation. Int J Cardiol. 2006 Nov 18; 113(3):401-5.
Score: 0.003
-
Uretsky BF, Generalovich T, Verbalis JG, Valdes AM, Reddy PS. Comparative hemodynamic and hormonal response of enoximone and dobutamine in severe congestive heart failure. Am J Cardiol. 1986 Jul 01; 58(1):110-6.
Score: 0.003
-
Uretsky BF. Is inotropic therapy appropriate for patients with chronic congestive heart failure? Or is the digitalis leaf withering? Postgrad Med J. 1986 Jun; 62(728):585-92.
Score: 0.003
-
Rahko PS, Shaver JA, Salerni R, Uretsky BF. Noninvasive evaluation of systolic and diastolic function in severe congestive heart failure secondary to coronary artery disease or idiopathic dilated cardiomyopathy. Am J Cardiol. 1986 Jun 01; 57(15):1315-22.
Score: 0.003
-
Shilling K, Uretsky BF, Hunter GC. Entrapment of a cerebral embolic protection device--a case report. Vasc Endovascular Surg. 2006 May-Jun; 40(3):229-33.
Score: 0.003
-
Uretsky BF, Valdes AM, Reddy PS. Positive inotropic therapy for short-term support and long-term management of patients with congestive heart failure: hemodynamic effects and clinical efficacy of MDL 17,043. Circulation. 1986 Mar; 73(3 Pt 2):III219-29.
Score: 0.003
-
Budoff MJ, Achenbach S, Fayad Z, Berman DS, Poon M, Taylor AJ, Uretsky BF, Williams KA. Task Force 12: training in advanced cardiovascular imaging (computed tomography): endorsed by the American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Atherosclerosis Imaging and Prevention, and Society of Cardiovascular Computed Tomography. J Am Coll Cardiol. 2006 Feb 21; 47(4):915-20.
Score: 0.003
-
Rangasetty UC, Raza S, Lick S, Uretsky BF, Birnbaum Y. Chronic pseudoaneurysm and coarctation of the aorta: a rare delayed complication of trauma. Tex Heart Inst J. 2006; 33(3):368-70.
Score: 0.003
-
Schwarz ER, Gupta R, Diep TP, Nowak B, Kostin S, Grohmann B, Uretsky BF, Schaper J. Carvedilol improves myocardial contractility compared with metoprolol in patients with chronic hibernating myocardium after revascularization. J Cardiovasc Pharmacol Ther. 2005 Sep; 10(3):181-90.
Score: 0.002
-
Uretsky BF, Generalovich T, Verbalis JG, Valdes AM, Reddy PS. MDL 17,043 therapy in severe congestive heart failure: characterization of the early and late hemodynamic, pharmacokinetic, hormonal and clinical response. J Am Coll Cardiol. 1985 Jun; 5(6):1414-21.
Score: 0.002
-
Gupta R, Rahman MA, Uretsky BF, Schwarz ER. Left main coronary artery thrombus: a case series with different outcomes. J Thromb Thrombolysis. 2005 Apr; 19(2):125-31.
Score: 0.002
-
Uretsky BF, Verbalis JG, Generalovich T, Valdes A, Reddy PS. Plasma vasopressin response to osmotic and hemodynamic stimuli in heart failure. Am J Physiol. 1985 Mar; 248(3 Pt 2):H396-402.
Score: 0.002
-
Sanghi P, Uretsky BF, Schwarz ER. Vasopressin antagonism: a future treatment option in heart failure. Eur Heart J. 2005 Mar; 26(6):538-43.
Score: 0.002
-
Uretsky BF. Idiopathic "myocarditis"? J Am Coll Cardiol. 1984 Nov; 4(5):1069.
Score: 0.002
-
Uretsky BF, Generalovich T, Reddy PS, Salerni R, Valdes AM, Spangenberg RB, Lang JF, Okerholm RA. Acute hemodynamic effect of oral MDL 17,043 in severe congestive heart failure. Am J Cardiol. 1984 Aug 01; 54(3):357-62.
Score: 0.002
-
deFilippi C, Wasserman S, Rosanio S, Tiblier E, Sperger H, Tocchi M, Christenson R, Uretsky B, Smiley M, Gold J, Muniz H, Badalamenti J, Herzog C, Henrich W. Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis. JAMA. 2003 Jul 16; 290(3):353-9.
Score: 0.002
-
Uretsky BF, Generalovich T, Reddy PS, Spangenberg RB, Follansbee WP. The acute hemodynamic effects of a new agent, MDL 17,043, in the treatment of congestive heart failure. Circulation. 1983 Apr; 67(4):823-8.
Score: 0.002
-
Uretsky BF. Left ventricular aneurysm by angiogram: a problem of definition. Am J Cardiol. 1983 Mar 01; 51(5):918.
Score: 0.002
-
Poole-Wilson PA, Uretsky BF, Thygesen K, Cleland JG, Massie BM, Ryd?n L. Mode of death in heart failure: findings from the ATLAS trial. Heart. 2003 Jan; 89(1):42-8.
Score: 0.002
-
Birnbaum Y, Ashitkov T, Uretsky BF, Ballinger S, Motamedi M. Reduction of infarct size by short-term pretreatment with atorvastatin. Cardiovasc Drugs Ther. 2003 Jan; 17(1):25-30.
Score: 0.002
-
Mueller RN, Uretsky BF, Hao L, Walker DH, Panomitros GE, Zornow MH. Cardiac arrest on induction of anesthesia due to triple vessel coronary artery disease despite a "Negative" angiogram. Anesthesiology. 2002 Sep; 97(3):745-9.
Score: 0.002
-
Adams KF, Gheorghiade M, Uretsky BF, Patterson JH, Schwartz TA, Young JB. Clinical benefits of low serum digoxin concentrations in heart failure. J Am Coll Cardiol. 2002 Mar 20; 39(6):946-53.
Score: 0.002
-
Uretsky BF. Does mitral valve prolapse cause nonspecific symptoms? Int J Cardiol. 1982; 1(5-6):435-42.
Score: 0.002
-
Cleland JG, Thygesen K, Uretsky BF, Armstrong P, Horowitz JD, Massie B, Packer M, Poole-Wilson PA, Ryd?n L. Cardiovascular critical event pathways for the progression of heart failure; a report from the ATLAS study. Eur Heart J. 2001 Sep; 22(17):1601-12.
Score: 0.002
-
deFilippi CR, Rosanio S, Tocchi M, Parmar RJ, Potter MA, Uretsky BF, Runge MS. Randomized comparison of a strategy of predischarge coronary angiography versus exercise testing in low-risk patients in a chest pain unit: in-hospital and long-term outcomes. J Am Coll Cardiol. 2001 Jun 15; 37(8):2042-9.
Score: 0.002
-
Shah MR, Stinnett SS, McNulty SE, Gheorghiade M, Zannad F, Uretsky B, Adams KF, Califf RM, O'connor CM. Hemodynamics as surrogate end points for survival in advanced heart failure: an analysis from FIRST. Am Heart J. 2001 Jun; 141(6):908-14.
Score: 0.002
-
Rosanio S, Tocchi M, Uretsky BF, Stouffer GA. Use of intraluminal stents in the treatment of carotid, renal, and peripheral arterial disease. Am J Med Sci. 2000 Feb; 319(2):111-7.
Score: 0.002
-
Rosanio S, Tocchi M, Cutler D, Uretsky BF, Stouffer GA, deFilippi CR, MacInerney EJ, Runge SR, Aaron J, Otero J, Garg S, Runge MS. Queuing for coronary angiography during severe supply-demand mismatch in a US public hospital: analysis of a waiting list registry. JAMA. 1999 Jul 14; 282(2):145-52.
Score: 0.002
-
O'Connor CM, Gattis WA, Uretsky BF, Adams KF, McNulty SE, Grossman SH, McKenna WJ, Zannad F, Swedberg K, Gheorghiade M, Califf RM. Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: insights from the Flolan International Randomized Survival Trial (FIRST). Am Heart J. 1999 Jul; 138(1 Pt 1):78-86.
Score: 0.002
-
Adams KF, Sueta CA, Gheorghiade M, O'Connor CM, Schwartz TA, Koch GG, Uretsky B, Swedberg K, McKenna W, Soler-Soler J, Califf RM. Gender differences in survival in advanced heart failure. Insights from the FIRST study. Circulation. 1999 Apr 13; 99(14):1816-21.
Score: 0.002
-
Young JB, Gheorghiade M, Uretsky BF, Patterson JH, Adams KF. Superiority of "triple" drug therapy in heart failure: insights from the PROVED and RADIANCE trials. Prospective Randomized Study of Ventricular Function and Efficacy of Digoxin. Randomized Assessment of Digoxin and Inhibitors of Angiotensin-Converting Enzyme. J Am Coll Cardiol. 1998 Sep; 32(3):686-92.
Score: 0.002
-
Lo MW, Toh J, Emmert SE, Ritter MA, Furtek CI, Lu H, Colucci WS, Uretsky BF, Rucinska E. Pharmacokinetics of intravenous and oral losartan in patients with heart failure. J Clin Pharmacol. 1998 Jun; 38(6):525-32.
Score: 0.002
-
Adams KF, Gheorghiade M, Uretsky BF, Young JB, Patterson JH, Tomasko L, Packer M. Clinical predictors of worsening heart failure during withdrawal from digoxin therapy. Am Heart J. 1998 Mar; 135(3):389-97.
Score: 0.001
-
Adams KF, Gheorghiade M, Uretsky BF, Young JB, Ahmed S, Tomasko L, Packer M. Patients with mild heart failure worsen during withdrawal from digoxin therapy. J Am Coll Cardiol. 1997 Jul; 30(1):42-8.
Score: 0.001
-
Hinderliter AL, Willis PW, Barst RJ, Rich S, Rubin LJ, Badesch DB, Groves BM, McGoon MD, Tapson VF, Bourge RC, Brundage BH, Koerner SK, Langleben D, Keller CA, Murali S, Uretsky BF, Koch G, Li S, Clayton LM, J?bsis MM, Blackburn SD, Crow JW, Long WA. Effects of long-term infusion of prostacyclin (epoprostenol) on echocardiographic measures of right ventricular structure and function in primary pulmonary hypertension. Primary Pulmonary Hypertension Study Group. Circulation. 1997 Mar 18; 95(6):1479-86.
Score: 0.001
-
Colucci WS, Packer M, Bristow MR, Gilbert EM, Cohn JN, Fowler MB, Krueger SK, Hershberger R, Uretsky BF, Bowers JA, Sackner-Bernstein JD, Young ST, Holcslaw TL, Lukas MA. Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. US Carvedilol Heart Failure Study Group. Circulation. 1996 Dec 01; 94(11):2800-6.
Score: 0.001
-
Mateo R, Jethmalani S, Angus DC, Gorcsan J, Uretsky B, Fung J. Interferon-associated left ventricular dysfunction in a liver transplant recipient. Dig Dis Sci. 1996 Jul; 41(7):1500-3.
Score: 0.001
-
Lavee J, Kormos RL, Uretsky BF, Murali S, Donato W, Hardesty RL, Griffith BP. Prediction of mortality in patients awaiting cardiac transplantation: increased risk of sudden death in ischemic compared to idiopathic dilated cardiomyopathy. Isr J Med Sci. 1996 May; 32(5):282-7.
Score: 0.001
-
Estrada-Quintero T, Uretsky BF, Murali S, Griffith BP, Kormos RL. Neurohormonal activation and exercise function in patients with severe heart failure and patients with left ventricular assist system. A comparative study. Chest. 1995 Jun; 107(6):1499-503.
Score: 0.001
-
Lazar JM, Uretsky BF, Denys BG, Reddy PS, Counihan PJ, Ragosta M. Predisposing risk factors and natural history of acute neurologic complications of left-sided cardiac catheterization. Am J Cardiol. 1995 May 15; 75(15):1056-60.
Score: 0.001
-
Rubin DA, Uretsky BF, Zerbe TR, Estrada-Quintero T, Murali S. Increased plasma atrial natriuretic peptide levels after heart transplant: relation to ventricular expression and severity of rejection. Am Heart J. 1994 Oct; 128(4):769-73.
Score: 0.001
-
Murali S, Kormos RL, Uretsky BF, Schechter D, Reddy PS, Denys BG, Armitage JM, Hardesty RL, Griffith BP. Preoperative pulmonary hemodynamics and early mortality after orthotopic cardiac transplantation: the Pittsburgh experience. Am Heart J. 1993 Oct; 126(4):896-904.
Score: 0.001
-
Denys BG, Uretsky BF, Reddy PS. Ultrasound-assisted cannulation of the internal jugular vein. A prospective comparison to the external landmark-guided technique. Circulation. 1993 May; 87(5):1557-62.
Score: 0.001
-
Murali S, Uretsky BF, Armitage JM, Tokarczyk TR, Betschart AR, Kormos RL, Stein KL, Reddy PS, Hardesty RL, Griffith BP. Utility of prostaglandin E1 in the pretransplantation evaluation of heart failure patients with significant pulmonary hypertension. J Heart Lung Transplant. 1992 Jul-Aug; 11(4 Pt 1):716-23.
Score: 0.001
-
Sandhu JS, Uretsky BF, Reddy PS, Denys BG, Ruffner RJ, Breisblatt WM, Zerbe TR, Kormos RL, Armitage JM, Hardesty RL, et al. Potential limitations of percutaneous transluminal coronary angioplasty in heart transplant recipients. Am J Cardiol. 1992 May 01; 69(14):1234-7.
Score: 0.001
-
Zerbe T, Uretsky B, Kormos R, Armitage J, Wolyn T, Griffith B, Hardesty R, Duquesnoy R. Graft atherosclerosis: effects of cellular rejection and human lymphocyte antigen. J Heart Lung Transplant. 1992 May-Jun; 11(3 Pt 2):S104-10.
Score: 0.001
-
Estrada-Quintero T, Uretsky BF, Murali S, Hardesty RL. Prolonged intraaortic balloon support for septal rupture after myocardial infarction. Ann Thorac Surg. 1992 Feb; 53(2):335-7.
Score: 0.001
-
Hosenpud JD, DeMarco T, Frazier OH, Griffith BP, Uretsky BF, Menkis AH, O'Connell JB, Olivari MT, Valantine HA. Progression of systemic disease and reduced long-term survival in patients with cardiac amyloidosis undergoing heart transplantation. Follow-up results of a multicenter survey. Circulation. 1991 Nov; 84(5 Suppl):III338-43.
Score: 0.001
-
Murali S, Uretsky BF, Reddy PS, Tokarczyk TR, Betschart AR. Reversibility of pulmonary hypertension in congestive heart failure patients evaluated for cardiac transplantation: comparative effects of various pharmacologic agents. Am Heart J. 1991 Nov; 122(5):1375-81.
Score: 0.001
-
Kormos RL, Armitage JM, Hardesty RL, Hattler BG, del Nido P, Marrone GC, Lee A, Uretsky BF, Murali S, Griffith BP. Cardiac transplantation at the University of Pittsburgh: 1980 to 1991. Clin Transpl. 1991; 87-95.
Score: 0.001
-
Hosenpud JD, Uretsky BF, Griffith BP, O'Connell JB, Olivari MT, Valantine HA. Successful intermediate-term outcome for patients with cardiac amyloidosis undergoing heart transplantation: results of a multicenter survey. J Heart Transplant. 1990 Jul-Aug; 9(4):346-50.
Score: 0.001
-
Murali S, Uretsky BF, Betschart AR, Tokarczyk TR, Kolesar JA, Reddy PS. Differential hemodynamic effects of oral enoximone in severe congestive heart failure. Am J Cardiol. 1990 Feb 15; 65(7):515-9.
Score: 0.001
-
Villanueva FS, Murali S, Uretsky BF, Reddy PS, Griffith BP, Hardesty RL, Kormos RL. Resolution of severe pulmonary hypertension after heterotopic cardiac transplantation. J Am Coll Cardiol. 1989 Nov 01; 14(5):1239-43.
Score: 0.001
-
Murali S, Uretsky BF, Reddy PS, Griffith BP, Hardesty RL, Trento A. Hemodynamic abnormalities following cardiac transplantation: relationship to hypertension and survival. Am Heart J. 1989 Aug; 118(2):334-41.
Score: 0.001
-
Dowling RD, Reddy PS, Uretsky BF, Steed DL, Webster MW. Comparison of open versus percutaneous exposure of the femoral artery for balloon aortic valvuloplasty. J Vasc Surg. 1989 May; 9(5):749-50.
Score: 0.001
-
Ladowski JS, Kormos RL, Uretsky BF, Lee A, Curran M, Clark R, Armitage JM, Griffith BP, Hardesty RL. Posttransplantation diabetes mellitus in heart transplant recipients. J Heart Transplant. 1989 Mar-Apr; 8(2):181-3.
Score: 0.001
-
Murali S, Uretsky BF, Kolesar JA, Valdes AM, Reddy PS. The acute effect of an oral "inotropic" placebo on the exercise capacity of patients with chronic cardiac failure. Chest. 1988 Aug; 94(2):262-6.
Score: 0.001
-
Murali S, Uretsky BF, Valdes AM, Kolesar JA, Reddy PS. Acute hemodynamic and hormonal effects of CI-930, a new phosphodiesterase inhibitor, in severe congestive heart failure. Am J Cardiol. 1987 Jun 01; 59(15):1356-60.
Score: 0.001
-
Unverferth DV, O'Dorisio TM, Miller MM, Uretsky BF, Magorien RD, Leier CV, Thompson ME, Hamlin RL. Human and canine ventricular vasoactive intestinal polypeptide: decrease with heart failure. J Lab Clin Med. 1986 Jul; 108(1):11-6.
Score: 0.001
-
Unverferth DV, Baker PB, Swift SE, Chaffee R, Fetters JK, Uretsky BF, Thompson ME, Leier CV. Extent of myocardial fibrosis and cellular hypertrophy in dilated cardiomyopathy. Am J Cardiol. 1986 Apr 01; 57(10):816-20.
Score: 0.001
-
Itzkoff JM, Curtiss EI, Reddy PS, Uretsky BF, Shaver JA. Intermittent mitral regurgitation due to Beall valve dysfunction: analysis of 13 patients with atrial fibrillation. Am J Cardiol. 1984 Apr 01; 53(8):1071-4.
Score: 0.001
-
Follansbee WP, Curtiss EI, Medsger TA, Steen VD, Uretsky BF, Owens GR, Rodnan GP. Physiologic abnormalities of cardiac function in progressive systemic sclerosis with diffuse scleroderma. N Engl J Med. 1984 Jan 19; 310(3):142-8.
Score: 0.001
-
Reddy PS, Uretsky BF, Steinfeld M. The hemodynamic effects of intravenous verapamil in patients on chronic propranolol therapy. Am Heart J. 1984 Jan; 107(1):97-101.
Score: 0.001
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|